Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
APOA2,Apolipoprotein A-II,Lifestyle factors,X1050.Time spend outdoors in summer,45733,0.0140865924811551,0.0264121291908081,-0.0376811807328289,0.065854365695139,0.593805188944394
APOA2,Apolipoprotein A-II,Lifestyle factors,X1060.Time spent outdoors in winter,42509,0.02978652542155,0.0301078291349631,-0.0292248196829776,0.0887978705260777,0.322515831738022
APOA2,Apolipoprotein A-II,Physical activities,X1070.Time spent watching television (TV),47095,0.0651968562389337,0.026926415187905,0.0124210824706399,0.117972630007227,0.0154730305083907
APOA2,Apolipoprotein A-II,Physical activities,X1080.Time spent using computer,42488,-0.0392911768876431,0.0279802873157057,-0.0941325400264263,0.0155501862511402,0.160263144115412
APOA2,Apolipoprotein A-II,Physical activities,X1090.Time spent driving,40220,-0.0863421628100961,0.0310497837256288,-0.147199738912329,-0.0254845867078635,0.00542952529959311
APOA2,Apolipoprotein A-II,Lifestyle factors,X1160.Sleep duration,48412,-0.0367942507780965,0.0243510409223203,-0.0845222909858443,0.0109337894296513,0.130803439271706
APOA2,Apolipoprotein A-II,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32657,-0.0199249578082327,0.0177715416797595,-0.0547571795005614,0.014907263884096,0.262247399085572
APOA2,Apolipoprotein A-II,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32657,-0.00887702629442209,0.0158682109045003,-0.0399787196672426,0.0222246670783984,0.575889019320729
APOA2,Apolipoprotein A-II,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32657,0.0238246755521498,0.0188554710353501,-0.0131320476771363,0.0607813987814359,0.206430438822326
APOA2,Apolipoprotein A-II,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32657,0.0235860224866643,0.0191395321885013,-0.0139274606027982,0.0610995055761268,0.217864996178281
APOA2,Apolipoprotein A-II,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32657,0.0151651683121001,0.0194633868559108,-0.022983069925485,0.0533134065496852,0.435905646951494
APOA2,Apolipoprotein A-II,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32657,0.0164852845580181,0.037354588504215,-0.0567297089102433,0.0897002780262795,0.658993800312829
APOA2,Apolipoprotein A-II,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32657,-0.00386986616701159,0.036422557468471,-0.0752580788052147,0.0675183464711915,0.91538726437303
APOA2,Apolipoprotein A-II,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32657,0.0323315775471691,0.0288495780551056,-0.024213595440838,0.0888767505351761,0.26245051644235
APOA2,Apolipoprotein A-II,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32657,0.0465117217658247,0.0205963138459532,0.00614294662775644,0.0868804969038929,0.0239559425940371
APOA2,Apolipoprotein A-II,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32657,0.00123192490841073,0.0143274660848406,-0.0268499086178769,0.0293137584346984,0.931481674543023
APOA2,Apolipoprotein A-II,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32657,0.0103409476758808,0.0198189903417369,-0.0285042733939234,0.0491861687456851,0.601844806725852
APOA2,Apolipoprotein A-II,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32657,-0.00671280847894209,0.0121329186770515,-0.0304933290859631,0.0170677121280789,0.58009200309703
APOA2,Apolipoprotein A-II,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32657,-0.0193672282738724,0.0150714676216982,-0.0489073048124008,0.0101728482646561,0.198819459465113
APOA2,Apolipoprotein A-II,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32657,-0.00837294832076049,0.0216121739135474,-0.0507328091913134,0.0339869125497925,0.69845672188346
APOA2,Apolipoprotein A-II,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32657,-0.0153531903928755,0.0203018662954315,-0.0551448483319212,0.0244384675461701,0.449523865874443
APOA2,Apolipoprotein A-II,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32657,-0.0138417113254463,0.0284321943325139,-0.0695688122171737,0.041885389566281,0.626390163520996
APOA2,Apolipoprotein A-II,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32657,0.0355003334825434,0.0268429712546282,-0.0171118901765279,0.0881125571416147,0.186032322647452
APOA2,Apolipoprotein A-II,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32657,-0.00149259522618062,0.0161148296734216,-0.0330776613860869,0.0300924709337256,0.926205758322271
APOA2,Apolipoprotein A-II,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32657,-0.0136199071331096,0.0149963009351525,-0.0430126569660085,0.0157728426997894,0.363789846719109
APOA2,Apolipoprotein A-II,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32657,0.0324865035590008,0.0199413565776552,-0.00659855533320346,0.0715715624512051,0.103329820330792
APOA2,Apolipoprotein A-II,Health and medical history,X120040.Fatigue severity over the past week,32664,-0.00573970895613661,0.0430680900904466,-0.090153165533412,0.0786737476211388,0.893982667219393
APOA2,Apolipoprotein A-II,Health and medical history,X120041.Waking unrefreshed severity over the past week,32663,0.0318267564354157,0.0430210685978225,-0.0524945380163163,0.116148050887148,0.459445760423639
APOA2,Apolipoprotein A-II,Health and medical history,X120042.Cognitive symptoms severity over the past week,32661,-0.0462126755026051,0.0462594933395592,-0.136881282448141,0.0444559314429309,0.317829990948771
APOA2,Apolipoprotein A-II,Health and medical history,X120098.Mobility problems today,32667,0.0100517243836922,0.050446204085908,-0.0888228356246876,0.108926284392072,0.84206718804578
APOA2,Apolipoprotein A-II,Health and medical history,X120099.Self-care problems today,32667,0.0646293383257961,0.0784207998414681,-0.0890754293634813,0.218334106015073,0.409886699892644
APOA2,Apolipoprotein A-II,Health and medical history,X120100.Problems doing usual activities,32667,-0.0234341885853407,0.047707487272286,-0.116940863639021,0.0700724864683398,0.623294111040913
APOA2,Apolipoprotein A-II,Health and medical history,X120101.Pain or discomfort today,32667,0.0207931541586622,0.0432102028774362,-0.0638988434811127,0.105485151798437,0.630380528977921
APOA2,Apolipoprotein A-II,Health and medical history,X120102.Anxiety or depression today,32667,-0.0184337342490846,0.0505571931883653,-0.117525832898281,0.0806583644001113,0.715410814656983
APOA2,Apolipoprotein A-II,Health and medical history,X120103.Scale to indicate how health is today,32628,-0.00226503801748373,0.00523032000498525,-0.0125164652272548,0.00798638919228736,0.66498321094888
APOA2,Apolipoprotein A-II,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32642,-0.0446964182358319,0.0520408595533005,-0.146696502960301,0.0573036664886371,0.390436481283319
APOA2,Apolipoprotein A-II,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32621,-0.0662523297832472,0.0524350190805088,-0.169024967181045,0.0365203076145501,0.206440933217879
APOA2,Apolipoprotein A-II,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32650,0.0250066377965084,0.0426593768679135,-0.058605740864602,0.108619016457619,0.557761815024109
APOA2,Apolipoprotein A-II,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32650,-0.027879204962074,0.0439539413496012,-0.114028930007292,0.0582705200831444,0.52591433862761
APOA2,Apolipoprotein A-II,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32653,-0.037000916235497,0.0529056026643213,-0.140695897457567,0.0666940649865727,0.484336834159789
APOA2,Apolipoprotein A-II,Health and medical history,X120109.Feeling bad about self over the last two weeks,32626,0.0264091731314489,0.0545102173868884,-0.0804308529468524,0.13324919920975,0.6280574190538
APOA2,Apolipoprotein A-II,Health and medical history,X120110.Trouble concentrating over the last two weeks,32650,-0.0769172682245084,0.0566824915340611,-0.188014951631268,0.0341804151822513,0.174823472547136
APOA2,Apolipoprotein A-II,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32641,0.137159229165345,0.0816202899056354,-0.0228165390497002,0.297134997380391,0.0929069598036299
APOA2,Apolipoprotein A-II,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32606,-0.0972210825008521,0.111989896905302,-0.316721280435244,0.12227911543354,0.385352178653505
APOA2,Apolipoprotein A-II,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30612,-0.0228694125837743,0.0562438562350641,-0.1331073708045,0.0873685456369513,0.684307299420887
APOA2,Apolipoprotein A-II,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46338,0.0257778027054717,0.0581286246874618,-0.0881543016819535,0.139709907092897,0.657436399215719
APOA2,Apolipoprotein A-II,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44708,0.0413153342582694,0.0380247178083358,-0.0332131126460687,0.115843781162608,0.277253579749521
APOA2,Apolipoprotein A-II,Diet and food preferences,X1289.Cooked vegetable intake,47929,-0.0359867302832783,0.0254231874283633,-0.0858161776428704,0.0138427170763138,0.156932811345144
APOA2,Apolipoprotein A-II,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47501,-0.0190960590609641,0.0274876716933782,-0.0729718955799853,0.0347797774580571,0.487241813032514
APOA2,Apolipoprotein A-II,Diet and food preferences,X1309.Fresh fruit intake,47993,-0.00181489235987114,0.0262775977731116,-0.0533189839951698,0.0496891992754275,0.944937556215717
APOA2,Apolipoprotein A-II,Diet and food preferences,X1319.Dried fruit intake,46480,-0.0376861116787967,0.0263949628168726,-0.089420238799867,0.0140480154422736,0.153370331641452
APOA2,Apolipoprotein A-II,Health and medical history,X134.Number of self-reported cancers,48668,-0.0585515621867816,0.0431999800018592,-0.143223522990426,0.0261203986168624,0.175315255132926
APOA2,Apolipoprotein A-II,Health and medical history,X135.Number of self-reported non-cancer illnesses,48668,0.13732316185045,0.025406625949182,0.0875261749900533,0.187120148710847,6.54153944975472e-08
APOA2,Apolipoprotein A-II,Health and medical history,"X136.Number of operations, self-reported",48668,0.0474732028222501,0.0256566536761237,-0.0028138383829524,0.0977602440274526,0.0642785847423132
APOA2,Apolipoprotein A-II,Health and medical history,X137.Number of treatments or medications taken,48668,0.18989158706506,0.0248282816042959,0.14122815512064,0.23855501900948,2.1138654633136e-14
APOA2,Apolipoprotein A-II,Diet and food preferences,X1438.Bread intake,47835,-0.0107181617965438,0.00350482240987166,-0.0175876137198923,-0.00384870987319538,0.00222983237283512
APOA2,Apolipoprotein A-II,Diet and food preferences,X1458.Cereal intake,47444,-0.137757280542449,0.0251683941112148,-0.18708733300043,-0.0884272280844682,4.46035211718197e-08
APOA2,Apolipoprotein A-II,Diet and food preferences,X1488.Tea intake,47846,0.00943656246276592,0.00325617687030047,0.003054455796977,0.0158186691285548,0.00375839635873707
APOA2,Apolipoprotein A-II,Diet and food preferences,X1498.Coffee intake,46772,-0.0822263040204856,0.0254914623397283,-0.132189570206353,-0.0322630378346182,0.00125871961681306
APOA2,Apolipoprotein A-II,Diet and food preferences,X1528.Water intake,47166,0.0625525949903005,0.02584579033838,0.0118948459270758,0.113210344053525,0.015518754164255
APOA2,Apolipoprotein A-II,Lifestyle factors,X1568.Average weekly red wine intake,39223,-0.0572667058156601,0.0316890219256235,-0.119377188789882,0.00484377715856185,0.070759775778397
APOA2,Apolipoprotein A-II,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39215,0.0770802888614903,0.0317526506890507,0.0148450935109509,0.13931548421203,0.0152142020649586
APOA2,Apolipoprotein A-II,Lifestyle factors,X1588.Average weekly beer plus cider intake,39243,-0.0282616410272322,0.0402496553370062,-0.107150965487764,0.0506276834332999,0.482591319975978
APOA2,Apolipoprotein A-II,Lifestyle factors,X1598.Average weekly spirits intake,39182,0.0194110506739704,0.035593348349469,-0.0503519120909888,0.0891740134389296,0.585516865352854
APOA2,Apolipoprotein A-II,Lifestyle factors,X1608.Average weekly fortified wine intake,39246,-0.00563652753564108,0.0542674583988669,-0.11200074599742,0.100727690926138,0.917277335565764
APOA2,Apolipoprotein A-II,Lifestyle factors,X1737.Childhood sunburn occasions,42898,-0.00616352432856653,0.030223436821155,-0.0654014604980304,0.0530744118408973,0.838408929049536
APOA2,Apolipoprotein A-II,Health and medical history,X1807.Father's age at death,42208,-0.003417610615366,0.00376536857490805,-0.0107977330221858,0.00396251179145377,0.364079159861781
APOA2,Apolipoprotein A-II,Health and medical history,X1845.Mother's age,33846,0.0134970761108809,0.00848704800111794,-0.00313753797131022,0.0301316901930721,0.111797565388228
APOA2,Apolipoprotein A-II,Health and medical history,X1873.Number of full brothers,48211,0.0146580459816751,0.0244332067157489,-0.0332310391811927,0.0625471311445429,0.548563184630771
APOA2,Apolipoprotein A-II,Health and medical history,X1883.Number of full sisters,48215,-0.00733410353634303,0.0244019908379415,-0.0551620055787084,0.0404937985060223,0.763757630583452
APOA2,Apolipoprotein A-II,Physical measures,X20015.Sitting height,48499,-0.018013981744312,0.00430909500568272,-0.0264598079554502,-0.00956815553317391,2.91953940607285e-05
APOA2,Apolipoprotein A-II,Cognitive function,X20016.Fluid intelligence score,32317,-0.0342622254713895,0.040602160860777,-0.113842460758512,0.0453180098157334,0.398777668297765
APOA2,Apolipoprotein A-II,Cognitive function,X20018.Prospective memory result,32616,0.0107204828593712,0.0528886206778117,-0.0929412136691398,0.114382179387882,0.839375174245478
APOA2,Apolipoprotein A-II,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32200,0.00239855674236484,0.00589782793838943,-0.00916118601687845,0.0139582995016081,0.684250767835613
APOA2,Apolipoprotein A-II,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32186,-0.0086824739395367,0.00590947779365593,-0.0202650504151023,0.00290010253602892,0.14180687372777
APOA2,Apolipoprotein A-II,Cognitive function,X20023.Mean time to correctly identify matches,48382,0.00720662328408094,0.00352997373165124,0.000287874770044509,0.0141253717981174,0.0412069809598161
APOA2,Apolipoprotein A-II,Health and medical history,X20107#1.Illnesses of father_Heart disease,45833,0.0147012780151633,0.00722490683119687,0.000540460626017421,0.0288620954043092,0.0418827885535318
APOA2,Apolipoprotein A-II,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45458,-0.0183692259291832,0.0156647972198339,-0.0490722284800577,0.0123337766216913,0.240952011058744
APOA2,Apolipoprotein A-II,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45429,0.035041140547622,0.0213770104198715,-0.00685779987532624,0.0769400809705701,0.101187144577854
APOA2,Apolipoprotein A-II,Health and medical history,X20107#12.Illnesses of father_Severe depression,45446,-0.00220573540581492,0.0169165243226443,-0.0353621230781978,0.0309506522665679,0.896259604205881
APOA2,Apolipoprotein A-II,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45452,-0.0142580620039901,0.0128069503710974,-0.039359684731341,0.0108435607233609,0.265589528132134
APOA2,Apolipoprotein A-II,Health and medical history,X20107#2.Illnesses of father_Stroke,45589,0.00430633267300987,0.00939596384475797,-0.0141097564627157,0.0227224218087355,0.646729216938037
APOA2,Apolipoprotein A-II,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45537,0.0171122575519503,0.0117951380544997,-0.00600621303486918,0.0402307281387698,0.146853475892076
APOA2,Apolipoprotein A-II,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45453,-0.00627427823844851,0.0150532613611497,-0.035778670506302,0.0232301140294049,0.676825128221463
APOA2,Apolipoprotein A-II,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45600,-0.00466309391947335,0.0105503142812415,-0.0253417099107068,0.0160155220717601,0.658503670330596
APOA2,Apolipoprotein A-II,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45638,0.00462034387445132,0.00804575553845186,-0.0111493369809143,0.020390024729817,0.565798953582376
APOA2,Apolipoprotein A-II,Health and medical history,X20107#9.Illnesses of father_Diabetes,45523,-0.0112093641662261,0.0111946666510012,-0.0331509108021885,0.0107321824697362,0.316687055127452
APOA2,Apolipoprotein A-II,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47045,-0.0152821834101694,0.00800402356175286,-0.030970069591205,0.000405702770866191,0.0562344254379715
APOA2,Apolipoprotein A-II,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46927,0.0219695263678819,0.0117412274069234,-0.00104327934968802,0.0449823320854518,0.0613381164253503
APOA2,Apolipoprotein A-II,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46870,-0.0110444335518262,0.0254072947947853,-0.0608427313496054,0.038753864245953,0.663787739626185
APOA2,Apolipoprotein A-II,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46903,0.00861050594424088,0.0126410637303414,-0.0161659789672282,0.03338699085571,0.495781335870769
APOA2,Apolipoprotein A-II,Health and medical history,X20110#2.Illnesses of mother_Stroke,46985,-0.000827106032032427,0.00923477300164069,-0.0189272611152482,0.0172730490511833,0.928634246321828
APOA2,Apolipoprotein A-II,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46884,0.00691055106648503,0.0170295136452912,-0.0264672956782858,0.0402883978112558,0.684894532534886
APOA2,Apolipoprotein A-II,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46881,0.00716456101890379,0.0151711303533035,-0.0225708544735712,0.0368999765113787,0.636753198071254
APOA2,Apolipoprotein A-II,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46910,0.00933790067091206,0.0119924054265546,-0.014167213965135,0.0328430153069591,0.436193423899169
APOA2,Apolipoprotein A-II,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46927,0.0321964262044688,0.0134905270671205,0.00575499315291259,0.058637859256025,0.0170134289112709
APOA2,Apolipoprotein A-II,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47073,-0.0015430718646111,0.00695934285874028,-0.0151833838677421,0.0120972401385198,0.82452867456528
APOA2,Apolipoprotein A-II,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46942,-0.035964431483493,0.0109545225623591,-0.057435295705717,-0.0144935672612691,0.00102840909045287
APOA2,Apolipoprotein A-II,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43904,0.00801217853172993,0.011353535206019,-0.0142407504720674,0.0302651075355273,0.480383788966153
APOA2,Apolipoprotein A-II,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43773,-0.0666718760588492,0.0449198304478552,-0.154714743736645,0.021370991618947,0.137761179500784
APOA2,Apolipoprotein A-II,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43770,0.00863245111690972,0.0470407041944797,-0.0835673291042705,0.10083223133809,0.854399607465655
APOA2,Apolipoprotein A-II,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43829,0.0130484983479615,0.0126841741927515,-0.0118124830698315,0.0379094797657545,0.303622824718193
APOA2,Apolipoprotein A-II,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43783,0.0241965100929158,0.0267553240965309,-0.0282439251362848,0.0766369453221165,0.365814519536345
APOA2,Apolipoprotein A-II,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43798,0.0400626555058818,0.0192585357853814,0.00231592536653423,0.0778093856452294,0.037515326236695
APOA2,Apolipoprotein A-II,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43778,-0.0105231654308793,0.0233664758019283,-0.0563214580026589,0.0352751271409002,0.6524608894216
APOA2,Apolipoprotein A-II,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43777,0.0274699158678231,0.0229886011147166,-0.0175877423170214,0.0725275740526676,0.232126550957285
APOA2,Apolipoprotein A-II,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43793,-0.00241152526534029,0.0165788394135328,-0.0349060505158645,0.0300829999851839,0.884350768883509
APOA2,Apolipoprotein A-II,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43799,0.0051634660994618,0.020327012019136,-0.0346774774580448,0.0450044096569684,0.799482863218278
APOA2,Apolipoprotein A-II,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43962,0.000962318961071977,0.00838397370482997,-0.0154702695003948,0.0173949074225387,0.908620072454319
APOA2,Apolipoprotein A-II,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43859,0.00548145739855316,0.0119998519200708,-0.0180382523647856,0.0290011671618919,0.647824408571098
APOA2,Apolipoprotein A-II,Mental health,X20127.Neuroticism score,43482,0.0419520957605204,0.0256212075191764,-0.00826547097706529,0.0921696624981061,0.10156402773464
APOA2,Apolipoprotein A-II,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32317,-0.00338525078068257,0.0413554813550918,-0.0844419942366625,0.0776714926752974,0.934762223335539
APOA2,Apolipoprotein A-II,Lifestyle factors,X20161.Pack years of smoking,30946,0.000382461263826641,0.00715745574363705,-0.013646151993702,0.0144110745213553,0.957386671231167
APOA2,Apolipoprotein A-II,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30946,0.00128469823785277,0.00705570127841826,-0.012544476267847,0.0151138727435526,0.855526054599665
APOA2,Apolipoprotein A-II,Cognitive function,X20191.Fluid intelligence score,30491,-0.0164939459151111,0.0473485733513475,-0.109297149683752,0.07630925785353,0.727588398365315
APOA2,Apolipoprotein A-II,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30491,-0.0196061167724803,0.0485865409460156,-0.114835737026671,0.0756235034817103,0.686572837928124
APOA2,Apolipoprotein A-II,Cognitive function,X20240.Maximum digits remembered correctly,29826,0.075463476488197,0.0505246577673115,-0.0235648527357336,0.174491805712128,0.135339783262962
APOA2,Apolipoprotein A-II,Physical measures,X20255.Spirometry QC measure,43011,-0.0363299002363647,0.0339763993207881,-0.102923642905109,0.0302638424323799,0.284962516645763
APOA2,Apolipoprotein A-II,Eye measures,X20261.avMSE,29790,0.00796784967721294,0.00669011458859531,-0.00514477491643388,0.0210804742708597,0.23371104694872
APOA2,Apolipoprotein A-II,Eye measures,X20262.Myopia diagnosis,29790,-0.0996881528715756,0.0618064726913318,-0.220828839346586,0.0214525336034347,0.106823625241524
APOA2,Apolipoprotein A-II,NMR metabolomics,X20280.Glucose-lactate,37950,-0.0160636923762304,0.00454487312929289,-0.0249716437096444,-0.00715574104281632,0.000409969514403955
APOA2,Apolipoprotein A-II,NMR metabolomics,X20281.Spectrometer-corrected alanine,37980,0.000959711680767092,0.00436177330679142,-0.0075893640005441,0.00950878736207829,0.825852771084807
APOA2,Apolipoprotein A-II,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32063,0.00454518210104464,0.0204665347742715,-0.0355692260565276,0.0446595902586169,0.824258551998245
APOA2,Apolipoprotein A-II,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32061,-0.00726348040435885,0.0385927103033384,-0.0829051925989021,0.0683782317901843,0.850718141364934
APOA2,Apolipoprotein A-II,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32060,0.0321518772971047,0.0484410335716099,-0.0627925485032508,0.12709630309746,0.506881792073386
APOA2,Apolipoprotein A-II,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32060,0.00598435730270931,0.0192379744766536,-0.0317220726715317,0.0436907872769503,0.75575590642633
APOA2,Apolipoprotein A-II,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32060,-0.0222818608001853,0.0379001930894087,-0.0965662392554264,0.0520025176550558,0.556610892338395
APOA2,Apolipoprotein A-II,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32066,-0.052892828360655,0.045540600948433,-0.142152406219584,0.0363667494982738,0.245498054873504
APOA2,Apolipoprotein A-II,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32066,-0.0224033670956952,0.0310551116621762,-0.0832713859535605,0.0384646517621701,0.470681447352291
APOA2,Apolipoprotein A-II,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32066,-0.0493019852117459,0.0337868280568644,-0.1155241682032,0.0169201977797083,0.144549320125685
APOA2,Apolipoprotein A-II,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32066,0.0703462866159364,0.0545709556599097,-0.0366127864774865,0.177305359709359,0.197409697577926
APOA2,Apolipoprotein A-II,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32066,0.0384458812433473,0.0651963219132381,-0.0893389097065993,0.166230672193294,0.555413301857643
APOA2,Apolipoprotein A-II,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32066,-0.0233399060577452,0.0354972061126091,-0.092914430038459,0.0462346179229686,0.510870418873141
APOA2,Apolipoprotein A-II,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32066,0.00049143908427119,0.0669598469410715,-0.130749860920229,0.131732739088771,0.994144322593111
APOA2,Apolipoprotein A-II,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32066,0.0934502727438147,0.0466807787818315,0.00195594633142496,0.184944599156204,0.045330847720264
APOA2,Apolipoprotein A-II,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32066,-0.014849679447683,0.0566425379654939,-0.125869053860051,0.0961696949646851,0.79320148475861
APOA2,Apolipoprotein A-II,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32066,0.00942701081652837,0.0261143084862336,-0.0417570338164895,0.0606110554495462,0.718116748907374
APOA2,Apolipoprotein A-II,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32066,-0.0286045817817166,0.0428998431256027,-0.112688274307898,0.0554791107444647,0.504935488959405
APOA2,Apolipoprotein A-II,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32067,0.022380880952655,0.0626946851385596,-0.100500701918922,0.145262463824232,0.721115090739746
APOA2,Apolipoprotein A-II,Diet and food preferences,X20600.Liking for adding salt to foods,33452,0.0223565778232372,0.0385962046409235,-0.0532919832729729,0.0980051389194473,0.562439793868937
APOA2,Apolipoprotein A-II,Diet and food preferences,X20601.Liking for aniseed,33452,0.0238946688199761,0.0384608099437535,-0.0514885186697808,0.0992778563097329,0.534435662374993
APOA2,Apolipoprotein A-II,Diet and food preferences,X20602.Liking for apple juice,33452,-0.0916061603486252,0.0382802297776318,-0.166635410712784,-0.0165769099844668,0.0167297611000242
APOA2,Apolipoprotein A-II,Diet and food preferences,X20603.Liking for apples,33452,0.0032747412393614,0.0396212337468567,-0.0743828769044777,0.0809323593832005,0.934130754265376
APOA2,Apolipoprotein A-II,Diet and food preferences,X20604.Liking for asparagus,33452,0.0745931243443734,0.0395042008820842,-0.00283510938451155,0.152021358073258,0.0590268822688883
APOA2,Apolipoprotein A-II,Diet and food preferences,X20605.Liking for aubergine,33452,0.0415608666710597,0.0383934728534622,-0.0336903401217262,0.116812073463846,0.279060228834537
APOA2,Apolipoprotein A-II,Diet and food preferences,X20606.Liking for avocados,33452,0.0525581582127032,0.03968580407144,-0.0252260177673191,0.130342334192726,0.185418290492292
APOA2,Apolipoprotein A-II,Diet and food preferences,X20607.Liking for bacon,33452,-0.174922224278776,0.0388528681727571,-0.25107384589738,-0.0987706026601719,6.81100430010641e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20608.Liking for baked or steamed fish,33452,-0.0323846195242801,0.0394148061979419,-0.109637639672246,0.044868400623686,0.41130594069174
APOA2,Apolipoprotein A-II,Diet and food preferences,X20609.Liking for bananas,33452,-0.0823924393005674,0.0401800488718469,-0.161145335089387,-0.00363954351174753,0.0403367090386652
APOA2,Apolipoprotein A-II,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33452,-0.261562932429291,0.0387014996307913,-0.337417871705642,-0.185707993152941,1.48128295394318e-11
APOA2,Apolipoprotein A-II,Diet and food preferences,X20611.Liking for beef steak,33452,-0.275359406282924,0.0386364753333961,-0.351086897936381,-0.199631914629468,1.1054490746773e-12
APOA2,Apolipoprotein A-II,Diet and food preferences,X20612.Liking for beetroot,33452,-0.00441913654211588,0.0395026090216898,-0.0818442502246278,0.073005977140396,0.910929389086124
APOA2,Apolipoprotein A-II,Diet and food preferences,X20613.Liking for bell pepper,33452,0.00968871392898704,0.0388083855498963,-0.0663757217488097,0.0857531496067838,0.802859736259985
APOA2,Apolipoprotein A-II,Diet and food preferences,X20614.Liking for bicycling,33452,0.0246436712847703,0.0383870590126094,-0.0505949643799441,0.0998823069494847,0.52090342992066
APOA2,Apolipoprotein A-II,Diet and food preferences,X20615.Liking for biscuits,33452,-0.0949700900119483,0.0386027411226452,-0.170631462612333,-0.0193087174115636,0.0139050080167375
APOA2,Apolipoprotein A-II,Diet and food preferences,X20616.Liking for bitter foods,33452,-0.00572886820885425,0.0386089032135042,-0.0814023185073224,0.0699445820896139,0.882044592793077
APOA2,Apolipoprotein A-II,Diet and food preferences,X20617.Liking for bitter or ale,33452,-0.046181350692285,0.0399988105739227,-0.124579019417173,0.0322163180326035,0.248298022201229
APOA2,Apolipoprotein A-II,Diet and food preferences,X20618.Liking for black olives,33452,0.047980686135605,0.0391071790026281,-0.028669384709546,0.124630756980756,0.21989145669213
APOA2,Apolipoprotein A-II,Diet and food preferences,X20619.Liking for black pepper,33452,0.098843623736794,0.0392341764889996,0.0219446378183548,0.175742609655233,0.0117752156885542
APOA2,Apolipoprotein A-II,Diet and food preferences,X20620.Liking for blue cheese,33452,0.0193576210802169,0.0387588645864508,-0.0566097535092266,0.0953249956696604,0.617483597247509
APOA2,Apolipoprotein A-II,Diet and food preferences,X20621.Liking for bolognese sauce,33452,-0.13702989758286,0.0388128193436389,-0.213103023496392,-0.0609567716693273,0.000416800542415749
APOA2,Apolipoprotein A-II,Diet and food preferences,X20622.Liking for broad beans,33452,0.0708383226166314,0.0389442370010798,-0.00549238190548504,0.147169027138748,0.0689495546506121
APOA2,Apolipoprotein A-II,Diet and food preferences,X20623.Liking for broccoli,33452,0.0384082118730093,0.0405764335172624,-0.0411215978208249,0.117938021566843,0.343886174175063
APOA2,Apolipoprotein A-II,Diet and food preferences,X20624.Liking for brown rice,33452,-0.0308085863405119,0.0388086332112784,-0.106873507434618,0.0452563347535938,0.427298417527643
APOA2,Apolipoprotein A-II,Diet and food preferences,X20625.Liking for brussel sprouts,33452,0.0249419267240066,0.0390950838982836,-0.0516844377166292,0.101568291164642,0.523502195930816
APOA2,Apolipoprotein A-II,Diet and food preferences,X20626.Liking for burgers (meat),33452,-0.190582235713603,0.0385575490723407,-0.266155031895391,-0.115009439531816,7.83997370675142e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20627.Liking for burn of spicy foods,33452,0.00682606455388364,0.0385400314158511,-0.0687123970211844,0.0823645261289517,0.859421093836823
APOA2,Apolipoprotein A-II,Diet and food preferences,X20628.Liking for butter on bread,33452,-0.0111763037897334,0.0393609004965059,-0.0883236687628849,0.0659710611834181,0.776459596086743
APOA2,Apolipoprotein A-II,Diet and food preferences,X20629.Liking for butternut squash,33452,0.0403089076693469,0.0388913991176881,-0.0359182346013217,0.116536049940015,0.300021122745997
APOA2,Apolipoprotein A-II,Diet and food preferences,X20630.Liking for cabbage,33452,0.0266803603915335,0.0392372118505871,-0.0502245748356173,0.103585295618684,0.49653719632731
APOA2,Apolipoprotein A-II,Diet and food preferences,X20631.Liking for cake,33452,-0.0269537422629445,0.0385676596586006,-0.102546355193802,0.0486388706679128,0.484651970798294
APOA2,Apolipoprotein A-II,Diet and food preferences,X20632.Liking for cake icing,33452,-0.0303420485134413,0.0383402611216406,-0.105488960311857,0.0448048632849742,0.428738091862219
APOA2,Apolipoprotein A-II,Diet and food preferences,X20633.Liking for capers,33452,0.0126191467444584,0.0383525756424005,-0.0625519015146467,0.0877901950035634,0.742140700288946
APOA2,Apolipoprotein A-II,Diet and food preferences,X20634.Liking for cauliflower,33452,0.0439230446313437,0.0397104820131242,-0.0339095001143798,0.121755589377067,0.268720674644849
APOA2,Apolipoprotein A-II,Diet and food preferences,X20635.Liking for cereal or granola bar,33452,-0.0364373742657359,0.0383371894123588,-0.111578265513959,0.0387035169824872,0.34191194353614
APOA2,Apolipoprotein A-II,Diet and food preferences,X20636.Liking for cheesecake,33452,-0.0329025745129614,0.0384336311398933,-0.108232491547152,0.0424273425212295,0.39197186095149
APOA2,Apolipoprotein A-II,Diet and food preferences,X20637.Liking for cherries,33452,-0.0244648887154492,0.0423250512345889,-0.107421989135243,0.058492211704345,0.563262498882011
APOA2,Apolipoprotein A-II,Diet and food preferences,X20638.Liking for chicken,33452,-0.249294716501261,0.0411078089187333,-0.329866021981979,-0.168723411020544,1.37776058175978e-09
APOA2,Apolipoprotein A-II,Diet and food preferences,X20639.Liking for chilli pepper,33452,0.0132787474482226,0.0387052812312922,-0.0625836037651101,0.0891410986615553,0.73155135945075
APOA2,Apolipoprotein A-II,Diet and food preferences,X20640.Liking for chips or french fries,33452,-0.0357138318724129,0.0388766220531581,-0.111912011096603,0.040484347351777,0.358305695272801
APOA2,Apolipoprotein A-II,Diet and food preferences,X20641.Liking for cigarette smoking,33452,-0.0654302026292527,0.0641375516628342,-0.191139803888408,0.0602793986299022,0.307682710209093
APOA2,Apolipoprotein A-II,Diet and food preferences,X20642.Liking for cod,33452,-0.044488468573359,0.0397789015514442,-0.12245511561419,0.0334781784674715,0.263428810301195
APOA2,Apolipoprotein A-II,Diet and food preferences,X20643.Liking for coffee with sugar,33452,-0.100245102618753,0.0441787296265878,-0.186835412686865,-0.0136547925506411,0.0232870095946474
APOA2,Apolipoprotein A-II,Diet and food preferences,X20644.Liking for coffee without sugar,33452,-0.0122299149598077,0.0396961209141599,-0.090034311951561,0.0655744820319457,0.758022193467999
APOA2,Apolipoprotein A-II,Diet and food preferences,X20645.Liking for coriander,33452,0.0203333291681336,0.038621440533188,-0.0553646942769148,0.096031352613182,0.598569293344102
APOA2,Apolipoprotein A-II,Diet and food preferences,X20646.Liking for corn flakes,33452,-0.0497673542508855,0.0386133311143283,-0.125449483234969,0.025914774733198,0.19747833510282
APOA2,Apolipoprotein A-II,Diet and food preferences,X20647.Liking for cream,33452,-0.0844150776137007,0.0384307604372038,-0.15973936807062,-0.0090907871567812,0.0280780536427901
APOA2,Apolipoprotein A-II,Diet and food preferences,X20648.Liking for croissant,33452,0.0481379303394495,0.0383963383255783,-0.0271188927786841,0.123394753457583,0.209979489273901
APOA2,Apolipoprotein A-II,Diet and food preferences,X20649.Liking for cucumber,33452,0.0103622482226533,0.039246893136222,-0.0665616623243418,0.0872861587696485,0.791764992804582
APOA2,Apolipoprotein A-II,Diet and food preferences,X20650.Liking for curry,33452,0.00888613531503492,0.0388251130121154,-0.0672110861887113,0.0849833568187812,0.818970525270967
APOA2,Apolipoprotein A-II,Diet and food preferences,X20651.Liking for dairy products,33452,-0.131609647539231,0.0391381353496594,-0.208320392824564,-0.0548989022538988,0.000775074808274318
APOA2,Apolipoprotein A-II,Diet and food preferences,X20652.Liking for dark chocolate,33452,-0.040218070826228,0.0388168938250183,-0.116299182723264,0.0358630410708079,0.300184713437562
APOA2,Apolipoprotein A-II,Diet and food preferences,X20653.Liking for diet fizzy drinks,33452,-0.0139506500478916,0.0403940410130709,-0.0931229704335105,0.0652216703377272,0.729828771380871
APOA2,Apolipoprotein A-II,Diet and food preferences,X20654.Liking for dried fruit,33452,-0.0268331022551791,0.0389695022246758,-0.103213326615544,0.0495471221051855,0.491113737197382
APOA2,Apolipoprotein A-II,Diet and food preferences,X20655.Liking for eggs,33452,-0.000379882127705842,0.0400052751542557,-0.078790221430047,0.0780304571746353,0.992423771610361
APOA2,Apolipoprotein A-II,Diet and food preferences,X20656.Liking for exercising alone,33452,0.0934490631544312,0.0384629516430558,0.0180616779340418,0.168836448374821,0.0151355135869631
APOA2,Apolipoprotein A-II,Diet and food preferences,X20657.Liking for exercising with others,33452,0.00462188689031897,0.0383908261991182,-0.0706241324599526,0.0798679062405906,0.90417658649159
APOA2,Apolipoprotein A-II,Diet and food preferences,X20658.Liking for extra virgin olive oil,33452,0.0536144739172735,0.0394527383095468,-0.0237128931694383,0.130941841003985,0.174195113682614
APOA2,Apolipoprotein A-II,Diet and food preferences,X20659.Liking for fatty foods,33452,-0.0136709450363437,0.0388212931654095,-0.0897606796405463,0.0624187895678589,0.724733511028096
APOA2,Apolipoprotein A-II,Diet and food preferences,X20660.Liking for fresh tomatoes,33452,0.0341120555514194,0.0427711955356154,-0.0497194876983868,0.117943598801226,0.425154251027745
APOA2,Apolipoprotein A-II,Diet and food preferences,X20661.Liking for fried chicken,33452,-0.20396617579661,0.0383592553618605,-0.279150316305856,-0.128782035287363,1.07870380664703e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20662.Liking for fried or battered fish,33452,-0.0642339465358249,0.0387519653851146,-0.140187798690649,0.0117199056189997,0.0974399514892412
APOA2,Apolipoprotein A-II,Diet and food preferences,X20663.Liking for fruit,33452,-0.0324540966078074,0.0451086510848462,-0.120867052734106,0.0559588595184911,0.471873146576437
APOA2,Apolipoprotein A-II,Diet and food preferences,X20664.Liking for garlic,33452,0.0556962562346989,0.0392216346408052,-0.0211781476612793,0.132570660130677,0.155630959859564
APOA2,Apolipoprotein A-II,Diet and food preferences,X20665.Liking for gherkins,33452,0.0336280340837255,0.0384187646740204,-0.0416727446773545,0.108928812844805,0.381432810716851
APOA2,Apolipoprotein A-II,Diet and food preferences,X20666.Liking for globe artichoke,33452,0.119605580805224,0.0386412315576432,0.0438687669522432,0.195342394658205,0.00197228868002047
APOA2,Apolipoprotein A-II,Diet and food preferences,X20667.Liking for goat's cheese,33452,0.0158164899320304,0.0386142388132861,-0.0598674181420104,0.0915003980060712,0.682107298197061
APOA2,Apolipoprotein A-II,Diet and food preferences,X20668.Liking for going to a cafe,33452,0.0451344677077816,0.0392384045778289,-0.031772805264763,0.122041740680326,0.250066338866049
APOA2,Apolipoprotein A-II,Diet and food preferences,X20669.Liking for going to the gym,33452,-0.00621646691800944,0.0383672672685955,-0.0814163107644566,0.0689833769284378,0.871289593422372
APOA2,Apolipoprotein A-II,Diet and food preferences,X20670.Liking for going to the pub,33452,-0.00437653215548289,0.0388144335003023,-0.0804528218160754,0.0716997575051096,0.910227094120177
APOA2,Apolipoprotein A-II,Diet and food preferences,X20671.Liking for grapefruit,33452,-0.00395454297879953,0.0386779269369616,-0.0797632797752442,0.0718541938176451,0.91856616590562
APOA2,Apolipoprotein A-II,Diet and food preferences,X20672.Liking for green olives,33452,0.0637838626720136,0.0390894923677669,-0.0128315423688096,0.140399267712837,0.102769429219513
APOA2,Apolipoprotein A-II,Diet and food preferences,X20673.Liking for haddock,33452,-0.0194241725328659,0.0395461149536573,-0.0969345578420343,0.0580862127763025,0.623312709497987
APOA2,Apolipoprotein A-II,Diet and food preferences,X20674.Liking for ham,33452,-0.247884348987533,0.0388149667229907,-0.323961683764594,-0.171807014210471,1.78356910121263e-10
APOA2,Apolipoprotein A-II,Diet and food preferences,X20675.Liking for hard cheese,33452,-0.00599015736387456,0.0399791426589371,-0.0843492769753912,0.0723689622476421,0.880900474178806
APOA2,Apolipoprotein A-II,Diet and food preferences,X20676.Liking for herring,33452,0.0710683966786085,0.0388007759120104,-0.00498112410893191,0.147117917466149,0.0670406626261879
APOA2,Apolipoprotein A-II,Diet and food preferences,X20677.Liking for honey,33452,-0.00158701753116555,0.038693586081161,-0.0774264462502411,0.07425241118791,0.967284846329843
APOA2,Apolipoprotein A-II,Diet and food preferences,X20678.Liking for horseradish or wasabi,33452,-0.00601280443731073,0.0386572782443406,-0.0817810697962182,0.0697554609215968,0.876398066206391
APOA2,Apolipoprotein A-II,Diet and food preferences,X20679.Liking for ice cream,33452,-0.0200043791733091,0.0387725152576502,-0.0959985090783036,0.0559897507316854,0.605907423863822
APOA2,Apolipoprotein A-II,Diet and food preferences,X20680.Liking for jam,33452,-0.0520096482080678,0.0384389077706852,-0.127349907438611,0.0233306110224752,0.176074640979566
APOA2,Apolipoprotein A-II,Diet and food preferences,X20681.Liking for kiwi fruit,33452,-0.0292965028818822,0.0389594939122649,-0.105657110949921,0.0470641051861569,0.452086743029895
APOA2,Apolipoprotein A-II,Diet and food preferences,X20682.Liking for lager,33452,-0.0748278892097745,0.0389333863323058,-0.151137326421094,0.0014815480015449,0.0546440460536979
APOA2,Apolipoprotein A-II,Diet and food preferences,X20683.Liking for lamb,33452,-0.197947582608312,0.0391024241084409,-0.274588333860856,-0.121306831355768,4.22474441014377e-07
APOA2,Apolipoprotein A-II,Diet and food preferences,X20684.Liking for lemons,33452,0.0125830078200565,0.0387464865017714,-0.0633601057234155,0.0885261213635286,0.745376158353449
APOA2,Apolipoprotein A-II,Diet and food preferences,X20685.Liking for lentils or beans,33452,0.0819568247550463,0.0391769690899437,0.00516996533875673,0.158743684171336,0.0364696796953791
APOA2,Apolipoprotein A-II,Diet and food preferences,X20686.Liking for liver,33452,-0.168765451384238,0.0390328079666777,-0.245269754998926,-0.0922611477695497,1.55100672226314e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,X20687.Liking for mackerel,33452,0.0697086206543632,0.0386513505161354,-0.00604802635726226,0.145465267665989,0.071339493084086
APOA2,Apolipoprotein A-II,Diet and food preferences,X20688.Liking for marzipan,33452,0.0319114799707014,0.0381988383046785,-0.0429582431064685,0.106781203047871,0.403512216757659
APOA2,Apolipoprotein A-II,Diet and food preferences,X20689.Liking for mayonnaise,33452,0.044252558161177,0.0386508029605201,-0.0315030156414425,0.120008131963796,0.252267620801554
APOA2,Apolipoprotein A-II,Diet and food preferences,X20690.Liking for melon,33452,-0.0687585161996179,0.0408684257787722,-0.148860630726011,0.0113435983267757,0.0925190229718488
APOA2,Apolipoprotein A-II,Diet and food preferences,X20691.Liking for milk chocolate,33452,-0.0444140062951076,0.0385201229545498,-0.119913447286025,0.0310854346958101,0.248937791626322
APOA2,Apolipoprotein A-II,Diet and food preferences,X20692.Liking for mushrooms,33452,-0.00817597469276179,0.0403423144193454,-0.0872469109546787,0.0708949615691551,0.83940147599247
APOA2,Apolipoprotein A-II,Diet and food preferences,X20694.Liking for orange juice,33452,-0.0877283908181176,0.0387109734361826,-0.163601898753035,-0.0118548828831998,0.0234603020545936
APOA2,Apolipoprotein A-II,Diet and food preferences,X20695.Liking for oranges,33452,-0.0663920016419751,0.0397899147861745,-0.144380234622877,0.011596231338927,0.0952387256008948
APOA2,Apolipoprotein A-II,Diet and food preferences,X20696.Liking for pasta,33452,-0.0125012490682623,0.0392534352469475,-0.0894379821522794,0.0644354840157549,0.750131834708402
APOA2,Apolipoprotein A-II,Diet and food preferences,X20697.Liking for pears,33452,-0.00684811955422029,0.039808448678913,-0.0848726789648897,0.0711764398564491,0.863420340991229
APOA2,Apolipoprotein A-II,Diet and food preferences,X20698.Liking for pizza,33452,-0.0371625630939844,0.0387411898614143,-0.113095295222356,0.0387701690343876,0.337457614043376
APOA2,Apolipoprotein A-II,Diet and food preferences,X20699.Liking for plain yogurt,33452,0.039610830464728,0.0391158782452115,-0.0370562908958864,0.116277951825342,0.311252952695327
APOA2,Apolipoprotein A-II,Diet and food preferences,X20700.Liking for plums,33452,-0.00858497269282169,0.0400032101373319,-0.0869912645619922,0.0698213191763488,0.830078529336238
APOA2,Apolipoprotein A-II,Diet and food preferences,X20701.Liking for pollock,33452,0.0109456819344399,0.0382870422630127,-0.064096920901065,0.0859882847699449,0.774972971764983
APOA2,Apolipoprotein A-II,Diet and food preferences,X20702.Liking for pork chop,33452,-0.262559847916686,0.038673848379862,-0.338360590741216,-0.186759105092157,1.19997464842935e-11
APOA2,Apolipoprotein A-II,Diet and food preferences,X20703.Liking for porridge,33452,-0.0356584738792927,0.0398071481580043,-0.113680484268981,0.0423635365103958,0.370393896737153
APOA2,Apolipoprotein A-II,Diet and food preferences,X20704.Liking for potato crisps,33452,0.0313742709024235,0.0388838627723224,-0.0448381001313285,0.107586641936175,0.419762007885814
APOA2,Apolipoprotein A-II,Diet and food preferences,X20705.Liking for potatoes,33452,0.0187348985427679,0.0392550087036888,-0.0582049185164622,0.0956747156019979,0.633187626997511
APOA2,Apolipoprotein A-II,Diet and food preferences,X20706.Liking for prawns,33452,-0.0427622151098577,0.039605558434851,-0.120389109642166,0.0348646794224502,0.280303702671718
APOA2,Apolipoprotein A-II,Diet and food preferences,X20707.Liking for raw carrots,33452,0.0964736768294615,0.0393663533999496,0.0193156241655603,0.173631729493363,0.0142782412938347
APOA2,Apolipoprotein A-II,Diet and food preferences,X20708.Liking for red meat,33452,-0.285469812562073,0.0388428807008511,-0.361601858735741,-0.209337766388405,2.16580558532406e-13
APOA2,Apolipoprotein A-II,Diet and food preferences,X20709.Liking for red wine,33452,-0.0114156605110939,0.038664942605982,-0.0871989480188186,0.0643676269966309,0.767812962224715
APOA2,Apolipoprotein A-II,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33452,-0.0779796105665247,0.0408026204439531,-0.157952746636673,0.00199352550362342,0.0560180711982034
APOA2,Apolipoprotein A-II,Diet and food preferences,X20711.Liking for roast chicken,33452,-0.256600569470552,0.0414143403518224,-0.337772676560124,-0.17542846238098,6.04838995775523e-10
APOA2,Apolipoprotein A-II,Diet and food preferences,X20712.Liking for salad dressing,33452,-0.00717260244446131,0.0383078647257299,-0.0822560173068919,0.0679108124179693,0.851480007269659
APOA2,Apolipoprotein A-II,Diet and food preferences,X20713.Liking for salad leaves,33452,0.0513925204619683,0.040416282856761,-0.0278233939372833,0.13060843486122,0.203555423116602
APOA2,Apolipoprotein A-II,Diet and food preferences,X20714.Liking for salami,33452,-0.124844445031978,0.0386495550712056,-0.200597572971541,-0.0490913170924154,0.00124163619767975
APOA2,Apolipoprotein A-II,Diet and food preferences,X20715.Liking for salmon,33452,-0.00615996089212681,0.0415547997736409,-0.0876073684484631,0.0752874466642094,0.882159018116451
APOA2,Apolipoprotein A-II,Diet and food preferences,X20716.Liking for salty foods,33452,0.0339283990078211,0.0386206848314028,-0.0417681432617284,0.109624941277371,0.379694124560449
APOA2,Apolipoprotein A-II,Diet and food preferences,X20717.Liking for salty pretzels,33452,-0.0151263339115328,0.0384328405609676,-0.0904547014110292,0.0602020335879636,0.693901701789361
APOA2,Apolipoprotein A-II,Diet and food preferences,X20718.Liking for sardines,33452,0.0519367250842579,0.0387559143749919,-0.0240248670907263,0.127898317259242,0.18024733618121
APOA2,Apolipoprotein A-II,Diet and food preferences,X20719.Liking for sausages (meat),33452,-0.1806673892458,0.0386553017800316,-0.256431780734662,-0.104902997756938,2.99968744230091e-06
APOA2,Apolipoprotein A-II,Diet and food preferences,X20720.Liking for savoury biscuits,33452,-0.0223535524486076,0.0387190442733531,-0.0982428792243797,0.0535357743271645,0.563732984938026
APOA2,Apolipoprotein A-II,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33452,-0.00725296332639552,0.0387903164353673,-0.0832819835397155,0.0687760568869244,0.851681544351294
APOA2,Apolipoprotein A-II,Diet and food preferences,X20722.Liking for skimmed milk,33452,-0.0387284056396609,0.0385934548864794,-0.11437157721716,0.0369147659378386,0.315648261343929
APOA2,Apolipoprotein A-II,Diet and food preferences,X20723.Liking for smoked fish,33452,0.051083301081536,0.0387779423300087,-0.0249214658852811,0.127088068048353,0.187761997344951
APOA2,Apolipoprotein A-II,Diet and food preferences,X20724.Liking for soft cheese,33452,-0.0558646082902276,0.0385427328528511,-0.131408364681816,0.0196791481013606,0.147255200991729
APOA2,Apolipoprotein A-II,Diet and food preferences,X20725.Liking for soy sauce,33452,-0.0680734339172702,0.038829666740551,-0.14417958072875,0.00803271289420987,0.07961385897167
APOA2,Apolipoprotein A-II,Diet and food preferences,X20726.Liking for soya milk,33452,0.0394301397083216,0.0387969868611597,-0.0366119545395514,0.115472233956195,0.309504546465275
APOA2,Apolipoprotein A-II,Diet and food preferences,X20727.Liking for spicy foods,33452,0.0134938018037586,0.0387249375133853,-0.0624070757224767,0.0893946793299939,0.727508529160979
APOA2,Apolipoprotein A-II,Diet and food preferences,X20728.Liking for spinach,33452,0.0750579374033148,0.0395477211775183,-0.00245559610462109,0.152571470911251,0.0577401979180636
APOA2,Apolipoprotein A-II,Diet and food preferences,X20729.Liking for spirits,33452,0.0144977276929061,0.0388013492452048,-0.0615529168276952,0.0905483722135075,0.708681141636521
APOA2,Apolipoprotein A-II,Diet and food preferences,X20730.Liking for strawberries,33452,-0.145136771403162,0.0442114627088858,-0.231791238312578,-0.0584823044937456,0.00103179033960302
APOA2,Apolipoprotein A-II,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33452,-0.115491461249148,0.0401898205397278,-0.194263509507015,-0.0367194129912817,0.00406709695738897
APOA2,Apolipoprotein A-II,Diet and food preferences,X20732.Liking for sweet foods,33452,-0.0116535065710843,0.0383206384048543,-0.0867619578445987,0.0634549447024302,0.761054759705849
APOA2,Apolipoprotein A-II,Diet and food preferences,X20733.Liking for taking the stairs,33452,0.0256957612024,0.0398464333906619,-0.0524032482432973,0.103794770648097,0.519028022613258
APOA2,Apolipoprotein A-II,Diet and food preferences,X20734.Liking for tea with sugar,33452,-0.0679740062962919,0.0515318154976935,-0.168976364671771,0.0330283520791874,0.187179729551308
APOA2,Apolipoprotein A-II,Diet and food preferences,X20735.Liking for tea without sugar,33452,-0.0209186498577898,0.0412964158427769,-0.101859624909632,0.0600223251940528,0.612483862437669
APOA2,Apolipoprotein A-II,Diet and food preferences,X20736.Liking for tomato ketchup,33452,-0.0922962332631313,0.038392899681671,-0.167546316639206,-0.0170461498870562,0.0162372238948475
APOA2,Apolipoprotein A-II,Diet and food preferences,X20737.Liking for tinned tuna,33452,-0.0404723279776989,0.0389917655866937,-0.116896188527619,0.0359515325722207,0.299311397461204
APOA2,Apolipoprotein A-II,Diet and food preferences,X20738.Liking for turnip (white),33452,0.0588225447307428,0.0384982682722826,-0.016634061082931,0.134279150544417,0.126565833217489
APOA2,Apolipoprotein A-II,Diet and food preferences,X20739.Liking for vegetables,33452,0.0749990616939127,0.0449416569254965,-0.0130865858800605,0.163084709267886,0.0951899668747422
APOA2,Apolipoprotein A-II,Diet and food preferences,X20740.Liking for vinegar,33452,-0.10625071379424,0.0384413798108776,-0.18159581822356,-0.0309056093649197,0.00572195273801678
APOA2,Apolipoprotein A-II,Diet and food preferences,X20741.Liking for watching television,33452,-0.0846909512067138,0.0390373425192163,-0.161204142544378,-0.00817775986904991,0.0300719495307088
APOA2,Apolipoprotein A-II,Diet and food preferences,X20742.Liking for whisky,33452,0.0261654109418527,0.0409659548904645,-0.0541278606434577,0.106458682527163,0.523027146508185
APOA2,Apolipoprotein A-II,Diet and food preferences,X20743.Liking for white bread,33452,0.00077899396661585,0.0384169103219887,-0.0745181502644819,0.0760761381977136,0.983822556869891
APOA2,Apolipoprotein A-II,Diet and food preferences,X20744.Liking for white rice,33452,-0.011735891228539,0.0386196286082841,-0.0874303633007758,0.0639585808436978,0.761223220821714
APOA2,Apolipoprotein A-II,Diet and food preferences,X20745.Liking for white wine,33452,0.0469287256014039,0.0385473675295158,-0.028624114756447,0.122481565959255,0.22347256680185
APOA2,Apolipoprotein A-II,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33452,-0.0701716947465043,0.0392911720222897,-0.147182391910192,0.00683900241718348,0.0741425854995067
APOA2,Apolipoprotein A-II,Diet and food preferences,X20747.Liking for whole milk,33452,-0.0872416827107584,0.0386162830044209,-0.162929597399423,-0.0115537680220935,0.0238951517884716
APOA2,Apolipoprotein A-II,Diet and food preferences,X20748.Liking for wholemeal bread,33452,0.00570218953337161,0.040979169328873,-0.0746169823512195,0.0860213614179628,0.889335927939666
APOA2,Apolipoprotein A-II,Diet and food preferences,X20749.Liking for working up a sweat,33452,0.0959628923987873,0.038424550497017,0.020650773424634,0.171275011372941,0.0125272070515227
APOA2,Apolipoprotein A-II,Physical measures,X21001.Body mass index (BMI),48581,-0.175187954508561,0.0124200541372253,-0.199531260617522,-0.150844648399599,5.32275405245408e-45
APOA2,Apolipoprotein A-II,Physical measures,X21002.Weight,48588,-0.0401387387489446,0.00775238955935004,-0.0553334222852706,-0.0249440552126185,2.26565650023113e-07
APOA2,Apolipoprotein A-II,Physical measures,X21021.Pulse wave Arterial Stiffness index,32524,-0.0148728315241014,0.00547792663551441,-0.0256095677297096,-0.00413609531849314,0.00664071725147323
APOA2,Apolipoprotein A-II,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32968,0.0585721099959259,0.0401256598667696,-0.0200741833429426,0.137218403334794,0.144404760720801
APOA2,Apolipoprotein A-II,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32982,-0.00617200935165027,0.0421228467509183,-0.0887327889834502,0.0763887702801497,0.883511183510909
APOA2,Apolipoprotein A-II,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32983,-0.00736221210376941,0.0421022293717892,-0.0898825816724763,0.0751581574649375,0.861189756020369
APOA2,Apolipoprotein A-II,Health and medical history,X21040.Satisfaction with bowel habits,32936,-0.01611468674092,0.0391690509786521,-0.0928860266590781,0.060656653177238,0.680779565373469
APOA2,Apolipoprotein A-II,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32921,-0.0414805440615371,0.0406662942461351,-0.121186480783962,0.0382253926608876,0.307746853350526
APOA2,Apolipoprotein A-II,Health and medical history,X21042.Greatest number of times bowels opened per day,32933,-0.0369463897868279,0.0421105208395644,-0.119483010632374,0.0455902310587183,0.380312077597589
APOA2,Apolipoprotein A-II,Health and medical history,X21043.Least number of times bowels opened per week,32851,-0.0434791623370003,0.0419308426996549,-0.125663614028324,0.0387052893543234,0.299800408448144
APOA2,Apolipoprotein A-II,Health and medical history,X21044.Average number of times bowels opened per day,32900,-0.00586325927390516,0.0475614902596214,-0.0990837801827631,0.0873572616349528,0.901890331684287
APOA2,Apolipoprotein A-II,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32985,-0.017409381909153,0.0423066569108135,-0.100330429454347,0.0655116656360415,0.680712940253106
APOA2,Apolipoprotein A-II,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32979,-0.0366188584896701,0.042809711901051,-0.12052589381573,0.0472881768363899,0.392361136742578
APOA2,Apolipoprotein A-II,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32983,0.0271089147163967,0.049949003324876,-0.0707911318003603,0.125008961233154,0.587328626602378
APOA2,Apolipoprotein A-II,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32982,-0.000976341975158112,0.0443646078058981,-0.0879309732747184,0.0859782893244021,0.982442705783837
APOA2,Apolipoprotein A-II,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32979,0.091743758702555,0.0655174701872318,-0.0366704828644192,0.220158000269529,0.161461510563557
APOA2,Apolipoprotein A-II,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32980,0.00185476035304056,0.048295571419152,-0.0928045596284973,0.0965140803345785,0.969366186419018
APOA2,Apolipoprotein A-II,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32980,-0.183969143660953,0.12121494721361,-0.421550440199629,0.0536121528777219,0.129124581045544
APOA2,Apolipoprotein A-II,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32984,0.0151949758910214,0.0460959094000404,-0.0751530065330578,0.1055429583151,0.741681394170021
APOA2,Apolipoprotein A-II,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32983,0.0131304032891691,0.0481468041386622,-0.0812373328226087,0.107498139400947,0.78507814475882
APOA2,Apolipoprotein A-II,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32746,0.0159286885389431,0.0435461265188951,-0.0694217194380913,0.101279096515978,0.714531954434607
APOA2,Apolipoprotein A-II,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32981,-0.0344359655915943,0.0435563859788953,-0.119806482110229,0.0509345509270406,0.429195587521945
APOA2,Apolipoprotein A-II,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32982,0.00720143328907509,0.0570954387764003,-0.104705626712669,0.11910849329082,0.899632193215736
APOA2,Apolipoprotein A-II,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32985,-0.0139968121843579,0.0421755823771028,-0.0966609536434794,0.0686673292747635,0.73999554631259
APOA2,Apolipoprotein A-II,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32984,-0.0302066990989798,0.0423118019017286,-0.113137830826368,0.0527244326284084,0.475304109190613
APOA2,Apolipoprotein A-II,Working and living environment,X21100.Water hardness (USGS classification),48462,0.0189147933473361,0.0247039395116926,-0.0295049280955814,0.0673345147902537,0.443886762324322
APOA2,Apolipoprotein A-II,Lifestyle factors,X2139.Age first had sexual intercourse,45237,0.00818091785321868,0.00397470997379632,0.000390486304577902,0.0159713494018595,0.0395792781147058
APOA2,Apolipoprotein A-II,Health and medical history,X2149.Lifetime number of sexual partners,43904,-0.0141922691612102,0.0277366427815071,-0.0685560890129642,0.0401715506905437,0.608881203641405
APOA2,Apolipoprotein A-II,Physical activities,X22032.IPAQ activity group,43105,0.063322770358479,0.0280577992917231,0.00832948374670177,0.118316056970256,0.0240277992770656
APOA2,Apolipoprotein A-II,Physical activities,X22033.Summed days activity,43713,0.00729669914389565,0.00373612487326026,-2.61056076944575e-05,0.0146195038954858,0.050832556790843
APOA2,Apolipoprotein A-II,Physical activities,X22034.Summed minutes activity,43105,0.00366714972697699,0.00375716411312589,-0.00369689193474975,0.0110311913887037,0.329056341907701
APOA2,Apolipoprotein A-II,Physical activities,X22037.MET minutes per week for walking,42192,0.00280494296634907,0.00382358110358629,-0.00468927599668007,0.0102991619293782,0.463208016170587
APOA2,Apolipoprotein A-II,Physical activities,X22038.MET minutes per week for moderate activity,43105,0.0116055609133075,0.00371173726527136,0.00433055587337561,0.0188805659532394,0.00177040177364604
APOA2,Apolipoprotein A-II,Physical activities,X22039.MET minutes per week for vigorous activity,43105,0.0361708902543815,0.0281793320320726,-0.0190606005284809,0.0914023810372438,0.199299142498639
APOA2,Apolipoprotein A-II,Physical activities,X22040.Summed MET minutes per week for all activity,42192,0.00665024463867569,0.00389384759190388,-0.000981696641455912,0.0142821859188073,0.0876751432865587
APOA2,Apolipoprotein A-II,Eye measures,X2217.Age started wearing glasses or contact lenses,45281,-0.00698460898538676,0.00357901351566968,-0.0139994754760993,3.02575053258e-05,0.0510055315791685
APOA2,Apolipoprotein A-II,Working and living environment,X22501.Year ended full time education,30302,0.00215621196075836,0.01660694632878,-0.0303934028436505,0.0347058267651672,0.896699096729985
APOA2,Apolipoprotein A-II,Lifestyle factors,X22506.Tobacco smoking,30270,0.12629819261611,0.108176192566801,-0.0857271448148208,0.33832353004704,0.243047088340588
APOA2,Apolipoprotein A-II,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47034,-0.0258029964651307,0.0584572564356955,-0.140379219079094,0.0887732261488325,0.658928120837094
APOA2,Apolipoprotein A-II,Physical measures,X23098.Weight,48220,-0.0371893415705699,0.00780850611204095,-0.0524940135501702,-0.0218846695909696,1.92173894710188e-06
APOA2,Apolipoprotein A-II,Physical measures,X23099.Body fat percentage,48221,-0.0134242654444821,0.00800488030283209,-0.029113830838033,0.00226529994906882,0.093553648098311
APOA2,Apolipoprotein A-II,Physical measures,X23100.Whole body fat mass,48215,-0.0419954558146349,0.00767075501295869,-0.0570301356400339,-0.0269607759892359,4.42565255461857e-08
APOA2,Apolipoprotein A-II,Physical measures,X23101.Whole body fat-free mass,48220,-0.0310806242413006,0.0064115070385808,-0.043647178036919,-0.0185140704456823,1.25732636836692e-06
APOA2,Apolipoprotein A-II,Physical measures,X23102.Whole body water mass,48220,-0.0316031043808149,0.00643496093324734,-0.0442156278099797,-0.0189905809516502,9.11413224137723e-07
APOA2,Apolipoprotein A-II,Physical measures,X23104.Body mass index (BMI),48220,-0.16951321343638,0.0125719760862055,-0.194154286565343,-0.144872140307417,2.77795685826176e-41
APOA2,Apolipoprotein A-II,Physical measures,X23105.Basal metabolic rate,48218,-0.0335827217313908,0.00699093494063947,-0.0472849542150442,-0.0198804892477374,1.56668170569367e-06
APOA2,Apolipoprotein A-II,Physical measures,X23106.Impedance of whole body,48214,0.0275840095126434,0.00523606464603715,0.0173213228064106,0.0378466962188762,1.39058514106411e-07
APOA2,Apolipoprotein A-II,Physical measures,X23107.Impedance of leg (right),48217,-0.00785654204222854,0.00430765938955362,-0.0162995544457536,0.000586470361296554,0.068186692065201
APOA2,Apolipoprotein A-II,Physical measures,X23108.Impedance of leg (left),48216,-0.00707039165979624,0.00425798634163638,-0.0154160448894035,0.00127526156981107,0.0968268486618855
APOA2,Apolipoprotein A-II,Physical measures,X23109.Impedance of arm (right),48209,0.0463129216176678,0.00524498541431491,0.0360327502056106,0.0565930930297251,1.11814084922127e-18
APOA2,Apolipoprotein A-II,Physical measures,X23110.Impedance of arm (left),48215,0.0497466801271742,0.00525588049915779,0.0394451543488249,0.0600482059055235,3.20087870195187e-21
APOA2,Apolipoprotein A-II,Physical measures,X23111.Leg fat percentage (right),48216,-0.0246159712541726,0.0126316484945773,-0.0493740023035441,0.000142059795198907,0.0513366018275381
APOA2,Apolipoprotein A-II,Physical measures,X23112.Leg fat mass (right),48215,-0.110731809209444,0.0144865450217718,-0.139125437452117,-0.0823381809667716,2.18920834490084e-14
APOA2,Apolipoprotein A-II,Physical measures,X23113.Leg fat-free mass (right),48215,-0.00383662418179189,0.0065319551852415,-0.0166392563448652,0.00896600798128145,0.556965992626123
APOA2,Apolipoprotein A-II,Physical measures,X23114.Leg predicted mass (right),48214,-0.00330592302881312,0.00655756053210293,-0.0161587416717349,0.00954689561410862,0.61416826750795
APOA2,Apolipoprotein A-II,Physical measures,X23115.Leg fat percentage (left),48211,-0.020492476113189,0.0130398658111304,-0.0460506131030045,0.00506566087662653,0.116074050413482
APOA2,Apolipoprotein A-II,Physical measures,X23116.Leg fat mass (left),48211,-0.112192928241719,0.0145479268159222,-0.140706864800927,-0.0836789916825116,1.28757060583041e-14
APOA2,Apolipoprotein A-II,Physical measures,X23117.Leg fat-free mass (left),48209,-0.00566827706024557,0.00669415811472087,-0.0187888269650985,0.00745227284460734,0.397143122442497
APOA2,Apolipoprotein A-II,Physical measures,X23118.Leg predicted mass (left),48208,-0.00653381555281244,0.00672180844760396,-0.0197085601101162,0.00664092900449132,0.331044330375593
APOA2,Apolipoprotein A-II,Physical measures,X23119.Arm fat percentage (right),48208,-0.00912060643728621,0.00887795887487727,-0.0265214058320457,0.00828019295747323,0.304274874186677
APOA2,Apolipoprotein A-II,Physical measures,X23120.Arm fat mass (right),48207,-0.0624307490294445,0.00799161587489363,-0.078094316144236,-0.046767181914653,5.85939790614105e-15
APOA2,Apolipoprotein A-II,Physical measures,X23121.Arm fat-free mass (right),48208,-0.0402250799010617,0.0062483503557082,-0.0524718465982497,-0.0279783132038736,1.23604156764103e-10
APOA2,Apolipoprotein A-II,Physical measures,X23122.Arm predicted mass (right),48207,-0.0403924775502265,0.00624278035337745,-0.0526283270428463,-0.0281566280576067,9.97335200549367e-11
APOA2,Apolipoprotein A-II,Physical measures,X23123.Arm fat percentage (left),48204,-0.00383288370300802,0.00997892978211692,-0.0233915860759572,0.0157258186699411,0.700909494856394
APOA2,Apolipoprotein A-II,Physical measures,X23124.Arm fat mass (left),48204,-0.0565119102109081,0.00820783429689635,-0.0725992654328249,-0.0404245549889912,5.91780942636486e-12
APOA2,Apolipoprotein A-II,Physical measures,X23125.Arm fat-free mass (left),48204,-0.0468373186531048,0.00672869789649473,-0.0600255665302345,-0.0336490707759751,3.47076864219549e-12
APOA2,Apolipoprotein A-II,Physical measures,X23126.Arm predicted mass (left),48202,-0.0434848864925361,0.00674177903892809,-0.0566987734088351,-0.030270999576237,1.13957028354676e-10
APOA2,Apolipoprotein A-II,Physical measures,X23127.Trunk fat percentage,48201,-0.00792595419002955,0.00505525402734282,-0.0178342520836215,0.00198234370356237,0.116926041296911
APOA2,Apolipoprotein A-II,Physical measures,X23128.Trunk fat mass,48197,-0.0191478242899371,0.00583332482871176,-0.0305811409542121,-0.00771450762566202,0.00103043593230818
APOA2,Apolipoprotein A-II,Physical measures,X23129.Trunk fat-free mass,48192,-0.0364159687164199,0.0059814816004223,-0.0481396726532476,-0.0246922647795922,1.15997864243073e-09
APOA2,Apolipoprotein A-II,Physical measures,X23130.Trunk predicted mass,48189,-0.0360094010448754,0.00599515323996955,-0.0477599013952157,-0.0242589006945351,1.92425510587319e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23400.Total Cholesterol,37987,0.0300951908441463,0.0045066318712497,0.0212621923764969,0.0389281893117957,2.5171456026658e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37987,-0.00352278336156921,0.00436246562974355,-0.0120732159958666,0.00502764927272815,0.4193804718686
APOA2,Apolipoprotein A-II,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37987,-0.0240501675485856,0.00435202827349449,-0.0325801429646348,-0.0155201921325364,3.33293728832369e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23403.VLDL Cholesterol,37987,-0.0422804346650698,0.00425540777055288,-0.0506210338953534,-0.0339398354347862,3.49514118284523e-23
APOA2,Apolipoprotein A-II,NMR metabolomics,X23404.Clinical LDL Cholesterol,37987,0.00929617520341162,0.00436599716685317,0.000738820756379399,0.0178535296504438,0.0332539335896237
APOA2,Apolipoprotein A-II,NMR metabolomics,X23405.LDL Cholesterol,37987,0.0161784200526484,0.00436104909774158,0.00763076382107486,0.0247260762842219,0.000208290563004155
APOA2,Apolipoprotein A-II,NMR metabolomics,X23406.HDL Cholesterol,37987,0.111424770687099,0.00496196903803417,0.101699311372552,0.121150230001646,1.1201171853933e-109
APOA2,Apolipoprotein A-II,NMR metabolomics,X23407.Total Triglycerides,37987,-0.0518759002841533,0.00460010307221854,-0.0608921023057017,-0.042859698262605,2.30142924321447e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23408.Triglycerides in VLDL,37987,-0.0584713719466328,0.00459714574674036,-0.0674817776102439,-0.0494609662830217,7.53022545870357e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23409.Triglycerides in LDL,37987,-0.0135583400926267,0.00460319374046231,-0.0225805998239328,-0.00453608036132057,0.00323065270826567
APOA2,Apolipoprotein A-II,NMR metabolomics,X23410.Triglycerides in HDL,37987,-0.0243487084035864,0.00434828724465762,-0.0328713514031153,-0.0158260654040574,2.19016754071586e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37987,0.0293856064774164,0.00459240430677886,0.0203844940361298,0.0383867189187029,1.61821629911292e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23412.Phospholipids in VLDL,37987,-0.0517793960316428,0.00437739962596657,-0.0603590992985372,-0.0431996927647483,3.98824329153194e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23413.Phospholipids in LDL,37987,0.00708399578579215,0.00433084576479933,-0.00140446191321454,0.0155724534847988,0.101924124827555
APOA2,Apolipoprotein A-II,NMR metabolomics,X23414.Phospholipids in HDL,37987,0.0759146644157599,0.00484406309961073,0.0664203007405229,0.085409028090997,7.1661521667661e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23415.Total Esterified Cholesterol,37987,0.036983003176926,0.00451879192000604,0.0281261710137142,0.0458398353401379,2.98284504838215e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37987,-0.0385415436050623,0.00423142847910054,-0.0468351434240994,-0.0302479437860253,9.51794506290863e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37987,0.0127484232983391,0.00435202456117161,0.00421845515844271,0.0212783914382354,0.00340283730707836
APOA2,Apolipoprotein A-II,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37987,0.116091945313766,0.00492020874051672,0.106448336182354,0.125735554445179,1.16648768012166e-120
APOA2,Apolipoprotein A-II,NMR metabolomics,X23419.Total Free Cholesterol,37987,0.0124070897505958,0.00447123700554448,0.00364346521972862,0.021170714281463,0.00552999578744163
APOA2,Apolipoprotein A-II,NMR metabolomics,X23420.Free Cholesterol in VLDL,37987,-0.0468667827125121,0.00432895442597766,-0.0553515333874283,-0.0383820320375959,3.33780166343804e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23421.Free Cholesterol in LDL,37987,0.0253448330486776,0.00439690022373388,0.0167269086101592,0.033962757487196,8.38100346662412e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23422.Free Cholesterol in HDL,37987,0.0886874553265336,0.00501262842066446,0.0788627036220312,0.0985122070310359,2.86487652672506e-69
APOA2,Apolipoprotein A-II,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37987,0.00878493762137069,0.00449173534807396,-1.88636608542733e-05,0.0175887389035957,0.0505092184281824
APOA2,Apolipoprotein A-II,NMR metabolomics,X23424.Total Lipids in VLDL,37987,-0.0554691510626508,0.00446367225525008,-0.0642179486829409,-0.0467203534423606,2.91134533900766e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23425.Total Lipids in LDL,37987,0.012181427332003,0.0043526460411411,0.0036502410913664,0.0207126135726395,0.00513931614985328
APOA2,Apolipoprotein A-II,NMR metabolomics,X23426.Total Lipids in HDL,37987,0.0908003330415685,0.00488902572327932,0.081217842623941,0.100382823459196,4.73467462303539e-76
APOA2,Apolipoprotein A-II,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37987,0.0902817412790829,0.00456500383186864,0.0813343337686204,0.0992291487895455,7.63436591800311e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23428.Concentration of VLDL Particles,37987,-0.039009789909779,0.00432011950593057,-0.0474772241414029,-0.0305423556781551,1.94953141544877e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23429.Concentration of LDL Particles,37987,-0.0120677991965794,0.00431723862053548,-0.0205295868928289,-0.00360601150032985,0.00519312081074182
APOA2,Apolipoprotein A-II,NMR metabolomics,X23430.Concentration of HDL Particles,37987,0.0971243425823704,0.00456378877568829,0.0881793165820214,0.106069368582719,6.96811415944858e-99
APOA2,Apolipoprotein A-II,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37987,-0.0572705330505956,0.00485384148263201,-0.0667840623565543,-0.0477570037446368,5.66419684669031e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23432.Average Diameter for LDL Particles,37987,-0.00445945292674735,0.0044451165695726,-0.0131718814031096,0.00425297554961494,0.315770155055143
APOA2,Apolipoprotein A-II,NMR metabolomics,X23433.Average Diameter for HDL Particles,37987,0.0653527439067063,0.00525830926073056,0.0550464577556744,0.0756590300577382,2.85171617350135e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23434.Phosphoglycerides,37974,0.0361615369811965,0.00461348752991725,0.0271191014225587,0.0452039725398343,4.91002420670733e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37974,-0.0805521335827198,0.0048598725970084,-0.0900774838728562,-0.0710267832925833,4.23255630705512e-61
APOA2,Apolipoprotein A-II,NMR metabolomics,X23436.Total Cholines,37974,0.0442206768868874,0.00462205831827632,0.0351614425830658,0.053279911190709,1.28444883279454e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23437.Phosphatidylcholines,37974,0.0421555255017776,0.00462451680893899,0.0330914725562571,0.051219578447298,8.9064482369911e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23438.Sphingomyelins,37973,0.0533024237723809,0.00463989636657423,0.0442082268938954,0.0623966206508664,2.10115901493154e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23439.Apolipoprotein B,37987,-0.0178237316153711,0.00431448278001224,-0.026280117864195,-0.00936734536654708,3.63138651985224e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23440.Apolipoprotein A1,37987,0.0944610751213193,0.00472661294705809,0.0851969137450854,0.103725236497553,1.35928407794163e-87
APOA2,Apolipoprotein A-II,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37987,-0.0613037125570617,0.00432631515889842,-0.0697832902685026,-0.0528241348456207,2.96041571692297e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23442.Total Fatty Acids,37974,-0.00629015522074434,0.00463063080736009,-0.0153661916031701,0.00278588116168143,0.174365870741143
APOA2,Apolipoprotein A-II,NMR metabolomics,X23443.Degree of Unsaturation,37974,0.0454660031242561,0.00481499518997607,0.0360286125519031,0.0549033936966092,4.22385054430942e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23444.Omega-3 Fatty Acids,37974,-0.00160787076297222,0.00451583510905714,-0.0104589075767242,0.00724316605077978,0.721807403165112
APOA2,Apolipoprotein A-II,NMR metabolomics,X23445.Omega-6 Fatty Acids,37974,0.0249773870647574,0.00447912852087783,0.0161982951638369,0.0337564789656779,2.50261106399704e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37974,0.021617660690634,0.00451961179331571,0.0127592215757352,0.0304760998055328,1.74451877287938e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37974,-0.0197199472286386,0.00474643726263249,-0.0290229642633982,-0.0104169301938789,3.27740023739335e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23448.Saturated Fatty Acids,37974,-0.0195852136876829,0.00472020913508053,-0.0288368235924408,-0.0103336037829251,3.35642385645946e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23449.Linoleic Acid,37974,0.0249881396464011,0.00443413412223369,0.0162972367668231,0.0336790425259791,1.78135996987116e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23450.Docosahexaenoic Acid,37974,0.0358932722691492,0.00473402164663921,0.0266145898417363,0.045171954696562,3.62453140682259e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37974,0.00224857716724315,0.00449833933054993,-0.00656816792063471,0.011065322255121,0.617175958803194
APOA2,Apolipoprotein A-II,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37974,0.0628741793186271,0.00503691920646291,0.0530018176739598,0.0727465409632944,1.4575037034282e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37974,0.0667141935163134,0.00504187936012886,0.0568321099704608,0.0765962770621659,1.01213052940487e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37974,-0.0435400720915654,0.00499753331371003,-0.053335237386437,-0.0337449067966937,3.31994259974471e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37974,-0.0580000287336694,0.00468273732772005,-0.0671781938960007,-0.0488218635713381,4.82416365821812e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37974,0.0630294931591371,0.00483839799914758,0.0535462330808079,0.0725127532374664,1.46718718594351e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37974,0.0409656081982352,0.00478485273705373,0.0315872968336099,0.0503439195628605,1.23309926108502e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37974,0.0561688310880391,0.00503669386776631,0.0462969111072171,0.066040751068861,9.35340414079872e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37972,0.0120336777822477,0.00448229583594058,0.0032483779438042,0.0208189776206913,0.00726806311213319
APOA2,Apolipoprotein A-II,NMR metabolomics,X23460.Alanine,37980,0.00470168499336662,0.00434272179545608,-0.0038100497257273,0.0132134197124605,0.278979294257399
APOA2,Apolipoprotein A-II,NMR metabolomics,X23461.Glutamine,37942,0.0240142339666581,0.00436632359705515,0.01545623971643,0.0325722282168862,3.8697779070351e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23462.Glycine,37970,0.0642326800085723,0.00412014541121137,0.056157195002598,0.0723081650145466,2.53183110477758e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23463.Histidine,37968,-0.0134132793079687,0.00424917027927751,-0.0217416530553526,-0.00508490556058476,0.00159925808995158
APOA2,Apolipoprotein A-II,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37977,-0.0656195145218082,0.00431823109754538,-0.0740832474729971,-0.0571557815706192,1.00568291814148e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23465.Isoleucine,37983,-0.0570075639340101,0.00423881253320622,-0.0653156364990943,-0.0486994913689259,5.72304391231512e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23466.Leucine,37984,-0.0585956363724669,0.00432037187924264,-0.0670635652557824,-0.0501277074891513,1.24755190340956e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23467.Valine,37977,-0.0683669098260225,0.00435646875075525,-0.0769055885775028,-0.0598282310745422,5.14311376423055e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23468.Phenylalanine,37983,-0.0350411757638166,0.004240281447912,-0.0433521274017241,-0.0267302241259091,1.54042723900921e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23469.Tyrosine,37968,-0.0485574035122643,0.0042718501047404,-0.0569302297175555,-0.0401845773069731,8.35278409174543e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23470.Glucose,37960,-0.0217725153629481,0.00452404841278866,-0.0306396502520139,-0.0129053804738823,1.5057761009557e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23471.Lactate,37958,0.00800972215616314,0.00426338193320706,-0.000346506432922699,0.016365950745249,0.0603035743904438
APOA2,Apolipoprotein A-II,NMR metabolomics,X23472.Pyruvate,37944,0.000704506332834385,0.00435820882196085,-0.00783758295820888,0.00924659562387765,0.871583562136091
APOA2,Apolipoprotein A-II,NMR metabolomics,X23473.Citrate,37986,0.0224757017961957,0.00433504344519551,0.0139790166436125,0.0309723869487789,2.19534505720481e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23474.3-Hydroxybutyrate,37819,0.0470137487627051,0.00408449744954202,0.0390081337616027,0.0550193637638074,1.63031136013852e-30
APOA2,Apolipoprotein A-II,NMR metabolomics,X23475.Acetate,37977,0.00493803765908496,0.00440647391479903,-0.00369865121392114,0.0135747265320911,0.262464244119764
APOA2,Apolipoprotein A-II,NMR metabolomics,X23476.Acetoacetate,37986,-0.00639261154959592,0.00423300959469968,-0.0146893103552073,0.00190408725601544,0.131020537345971
APOA2,Apolipoprotein A-II,NMR metabolomics,X23477.Acetone,37986,0.00812265543199115,0.00425534666392419,-0.000217824029300265,0.0164631348932826,0.0563075184784929
APOA2,Apolipoprotein A-II,NMR metabolomics,X23478.Creatinine,37582,0.0562878226302722,0.0051078484111879,0.0462764397443439,0.0662992055162005,4.0702885546304e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23479.Albumin,37985,0.0198811856181972,0.00438151774303499,0.0112934108418486,0.0284689603945458,5.74119370995841e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23480.Glycoprotein Acetyls,37987,-0.00554599938100706,0.00469408330839268,-0.0147464026654567,0.00365440390344259,0.23742999072817
APOA2,Apolipoprotein A-II,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37987,-0.0795411694489757,0.00462202513934195,-0.088600338722086,-0.0704820001758655,1.13137333527536e-65
APOA2,Apolipoprotein A-II,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37987,-0.08283818766175,0.00461710948452879,-0.0918877222514265,-0.0737886530720736,3.71894159070811e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37987,-0.0760497053861922,0.00456070709527211,-0.0849886912929255,-0.0671107194794588,8.23544568369953e-62
APOA2,Apolipoprotein A-II,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37987,-0.0708842496552002,0.00455355755455134,-0.0798092224621208,-0.0619592768482795,3.60704048711156e-54
APOA2,Apolipoprotein A-II,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37987,-0.0691293759765672,0.00452057656509017,-0.0779897060441439,-0.0602690459089904,2.36113223580795e-52
APOA2,Apolipoprotein A-II,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37987,-0.0707057829149227,0.00458050813154264,-0.0796835788527463,-0.0617279869770992,2.65641908080259e-53
APOA2,Apolipoprotein A-II,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37987,-0.0875526419172613,0.00464705167932022,-0.0966608632087289,-0.0784444206257937,3.51018935300465e-78
APOA2,Apolipoprotein A-II,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37987,-0.0671176917730173,0.00454343887421188,-0.0760228319664726,-0.058212551579562,5.30843465980314e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37987,-0.0716590659875346,0.00454630948626528,-0.0805698325806146,-0.0627482993944547,1.76718572217654e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37987,-0.0730306754911405,0.00451434949028967,-0.0818788004921083,-0.0641825504901728,2.5608196791579e-58
APOA2,Apolipoprotein A-II,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37987,-0.063279773208306,0.00439405838906223,-0.0718921276508679,-0.054667418765744,1.12479719524434e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37987,-0.0547352719421138,0.00430948301115621,-0.0631818586439799,-0.0462886852402476,9.44606493519532e-37
APOA2,Apolipoprotein A-II,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37987,-0.0711735155021838,0.00448258220967791,-0.0799593766331526,-0.0623876543712151,2.90583728876095e-56
APOA2,Apolipoprotein A-II,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37987,-0.0723648790922466,0.00459734863677226,-0.0813756824203203,-0.063354075764173,2.4662088975624e-55
APOA2,Apolipoprotein A-II,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37987,-0.0586395692601006,0.0045122592966743,-0.0674835974815822,-0.049795541038619,2.19834020135926e-38
APOA2,Apolipoprotein A-II,NMR metabolomics,X23496.Total Lipids in Large VLDL,37987,-0.0602311699870333,0.00449868560180433,-0.0690485937665697,-0.0514137462074968,1.27771667854246e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23497.Phospholipids in Large VLDL,37987,-0.0625075895050276,0.00447548338368067,-0.0712795369370418,-0.0537356420730135,5.03092089588651e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23498.Cholesterol in Large VLDL,37987,-0.0539865859589808,0.00435561484724137,-0.0625235910595739,-0.0454495808583878,4.32702079928748e-35
APOA2,Apolipoprotein A-II,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37987,-0.0479257708362398,0.00425642679722991,-0.0562683673588104,-0.0395831743136692,2.80194859773811e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37987,-0.0591604494032304,0.00446170290682576,-0.0679053871006089,-0.0504155117058519,7.03658663591239e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23501.Triglycerides in Large VLDL,37987,-0.0602595861637605,0.00456596964889104,-0.0692088866755869,-0.051310285651934,1.58995673232802e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37987,-0.0282191971385157,0.00429824472584421,-0.0366437568011704,-0.0197946374758611,5.38276493995767e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37987,-0.0326936142959181,0.0043411207394636,-0.0412022109452667,-0.0241850176465694,5.34780660497188e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37987,-0.0290128692124518,0.00428696829601344,-0.0374153270726381,-0.0206104113522654,1.36241202999577e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37987,-0.0130359551594596,0.00432583679502685,-0.0215145952777123,-0.00455731504120702,0.00258721806142769
APOA2,Apolipoprotein A-II,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37987,-0.00302480763196008,0.00440177312948493,-0.0116522829657505,0.00560266770183038,0.491981484494917
APOA2,Apolipoprotein A-II,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37987,-0.0238266763841719,0.00427853273511471,-0.0322126005449967,-0.0154407522233471,2.61250741890559e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37987,-0.0407982632443091,0.00449737306763445,-0.0496131144568726,-0.0319834120317456,1.33272274566939e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37987,-0.0276555622808165,0.00433048432713835,-0.0361433115620077,-0.0191678129996254,1.75555701929792e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23510.Total Lipids in Small VLDL,37987,-0.0280138331861317,0.00430591175396269,-0.0364534202238986,-0.0195742461483648,7.99457011673525e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23511.Phospholipids in Small VLDL,37987,-0.0221694139347666,0.00425574422671945,-0.0305106726191368,-0.0138281552503965,1.92345002788189e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23512.Cholesterol in Small VLDL,37987,-0.0256323865935716,0.00420489845010645,-0.0338739875557802,-0.0173907856313629,1.1182304195802e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37987,-0.0303377394187317,0.00417789156199782,-0.0385264068802474,-0.022149071957216,4.03732961092955e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37987,-0.0165639390622926,0.00426501477533523,-0.0249233680219496,-0.0082045101026355,0.000103377887516231
APOA2,Apolipoprotein A-II,NMR metabolomics,X23515.Triglycerides in Small VLDL,37987,-0.0269402570259781,0.00446733306583653,-0.0356962298350176,-0.0181842842169385,1.67709097728432e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37987,-0.0385783463555521,0.00434822238849657,-0.0471008622370053,-0.0300558304740988,8.05991639786158e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37987,-0.0425116915247179,0.00434363799628682,-0.05102522199744,-0.0339981610519957,1.51921622688835e-22
APOA2,Apolipoprotein A-II,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37987,-0.0485064711557629,0.00433055919828841,-0.0569943671844082,-0.0400185751271176,5.40879265584401e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37987,-0.0379788475175496,0.00442519552924431,-0.0466522307548684,-0.0293054642802307,1.02937585212254e-17
APOA2,Apolipoprotein A-II,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37987,-0.0359298249148812,0.00446086617740885,-0.0446731226226026,-0.0271865272071599,8.64743505530802e-16
APOA2,Apolipoprotein A-II,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37987,-0.0411938756928845,0.00435482433900685,-0.0497293313973379,-0.0326584199884311,3.60141832636351e-21
APOA2,Apolipoprotein A-II,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37987,-0.0309582459741207,0.00443418704148007,-0.0396492525754217,-0.0222672393728198,3.05183902776411e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23523.Concentration of IDL Particles,37987,-0.0241800158683799,0.0043771927125687,-0.0327593135850146,-0.0156007181517453,3.37305373420806e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23524.Total Lipids in IDL,37987,-0.00245558314370151,0.00450369992246888,-0.0112828349917405,0.0063716687043375,0.585599616907997
APOA2,Apolipoprotein A-II,NMR metabolomics,X23525.Phospholipids in IDL,37987,-0.00611249952922768,0.00451449734509074,-0.0149609143256055,0.00273591526715017,0.175768162144269
APOA2,Apolipoprotein A-II,NMR metabolomics,X23526.Cholesterol in IDL,37987,0.00257395606460205,0.00451262320135886,-0.00627078541006132,0.0114186975392654,0.568422541022721
APOA2,Apolipoprotein A-II,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37987,0.000689862387077735,0.00450424908676718,-0.00813846582298593,0.0095181905971414,0.878275855119823
APOA2,Apolipoprotein A-II,NMR metabolomics,X23528.Free Cholesterol in IDL,37987,0.00786736428196107,0.00452930083185189,-0.00101006534846864,0.0167447939123908,0.0824111387732085
APOA2,Apolipoprotein A-II,NMR metabolomics,X23529.Triglycerides in IDL,37987,-0.0279758174618785,0.00449756384424573,-0.0367910425966001,-0.0191605923271569,5.11085276571572e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23530.Concentration of Large LDL Particles,37987,-0.0122439354161437,0.00433918151666723,-0.0207487311888115,-0.00373913964347595,0.00478371345861638
APOA2,Apolipoprotein A-II,NMR metabolomics,X23531.Total Lipids in Large LDL,37987,0.0186070403304304,0.00438698401653704,0.0100085516580178,0.027205529002843,2.23586466711569e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23532.Phospholipids in Large LDL,37987,0.0105709972144236,0.0043695089420984,0.00200675968791077,0.0191352347409365,0.015565028814164
APOA2,Apolipoprotein A-II,NMR metabolomics,X23533.Cholesterol in Large LDL,37987,0.02342788916788,0.00439896871875363,0.0148059104791229,0.0320498678566371,1.02135309128078e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37987,0.0220828132828171,0.00438045087978938,0.01349712955843,0.0306684970072043,4.68552222103511e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37987,0.0267910583123396,0.00444567917746802,0.0180775271245023,0.0355045895001769,1.72098042228456e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23536.Triglycerides in Large LDL,37987,-0.0129592507373664,0.00456587632382889,-0.0219083683320711,-0.00401013314266183,0.00454243920587567
APOA2,Apolipoprotein A-II,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37987,-0.00942143880230076,0.00430370772203126,-0.017856705937482,-0.000986171667119493,0.0286033461363049
APOA2,Apolipoprotein A-II,NMR metabolomics,X23538.Total Lipids in Medium LDL,37987,0.00383141030200592,0.00432398785295676,-0.00464360588978933,0.0123064264938012,0.375588773015047
APOA2,Apolipoprotein A-II,NMR metabolomics,X23539.Phospholipids in Medium LDL,37987,0.00524464790328182,0.00429240022786266,-0.003168456543329,0.0136577523498926,0.221787513839284
APOA2,Apolipoprotein A-II,NMR metabolomics,X23540.Cholesterol in Medium LDL,37987,0.00457627388109528,0.00432440039398132,-0.00389955089110812,0.0130520986532987,0.289962774026867
APOA2,Apolipoprotein A-II,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37987,-0.00282967860906104,0.00433917817820888,-0.0113344678383504,0.00567511062022836,0.514332794813988
APOA2,Apolipoprotein A-II,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37987,0.0242848735917165,0.00432409264869704,0.0158096520002703,0.0327600951831627,1.99071234757804e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23543.Triglycerides in Medium LDL,37987,-0.00627165909874202,0.00463528358415427,-0.0153568149236844,0.00281349672620035,0.176069930484448
APOA2,Apolipoprotein A-II,NMR metabolomics,X23544.Concentration of Small LDL Particles,37987,-0.0138801670205869,0.00429022303142649,-0.0222890041621829,-0.00547132987899101,0.00121806007480737
APOA2,Apolipoprotein A-II,NMR metabolomics,X23545.Total Lipids in Small LDL,37987,-0.00379430604262081,0.00433268559286207,-0.0122863698046305,0.00469775771938885,0.381186940252893
APOA2,Apolipoprotein A-II,NMR metabolomics,X23546.Phospholipids in Small LDL,37987,-0.00347563006564863,0.00431329967102425,-0.0119296974208562,0.00497843728955889,0.420375918638522
APOA2,Apolipoprotein A-II,NMR metabolomics,X23547.Cholesterol in Small LDL,37987,-0.000192435572818387,0.0043206754660045,-0.0086609594861872,0.00827608834055043,0.964475974257684
APOA2,Apolipoprotein A-II,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37987,-0.00670626207825862,0.00434841560391591,-0.0152291566619338,0.00181663250541657,0.123040806471333
APOA2,Apolipoprotein A-II,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37987,0.017338395719737,0.00429690262069254,0.00891646658317959,0.0257603248562943,5.48810075358259e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23550.Triglycerides in Small LDL,37987,-0.0281200347267892,0.00466715602719185,-0.0372676605400852,-0.0189724089134932,1.73402027094937e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37987,0.0538423246650295,0.00500458483476098,0.044033338388898,0.0636513109411611,6.93378298764953e-27
APOA2,Apolipoprotein A-II,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37987,0.0437905258760798,0.00504056459730965,0.0339110192653529,0.0536700324868067,4.12141631930455e-18
APOA2,Apolipoprotein A-II,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37987,0.0391086623245538,0.00504198308315746,0.0292263754815652,0.0489909491675424,9.34532877338651e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37987,0.0516058214086189,0.00500677950092865,0.0417925335867988,0.0614191092304391,8.07683816774951e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37987,0.0642889787239798,0.00507877090872508,0.0543345877428786,0.0742433697050809,1.61929280241793e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37987,0.00934706212021519,0.00467651261489367,0.00018109739502359,0.0185130268454068,0.0456580928090534
APOA2,Apolipoprotein A-II,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37987,0.00226775925938363,0.00452382772294445,-0.00659894307758748,0.0111344615963547,0.616173692068646
APOA2,Apolipoprotein A-II,NMR metabolomics,X23558.Concentration of Large HDL Particles,37987,0.0988690590039272,0.00525828317148479,0.088562823987817,0.109175294020037,7.05264532863872e-78
APOA2,Apolipoprotein A-II,NMR metabolomics,X23559.Total Lipids in Large HDL,37987,0.0903935897331812,0.00524051118951499,0.0801221878017318,0.100664991664631,5.76642379123191e-66
APOA2,Apolipoprotein A-II,NMR metabolomics,X23560.Phospholipids in Large HDL,37987,0.0828590493063478,0.0051788473037569,0.0727085085909843,0.0930095900217113,4.29531947035154e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23561.Cholesterol in Large HDL,37987,0.0971147811325846,0.00523524902240922,0.0868536930486626,0.107375869216507,7.07179267648802e-76
APOA2,Apolipoprotein A-II,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37987,0.102521482623233,0.00521203801813622,0.0923058881076857,0.11273707713878,5.94638766012936e-85
APOA2,Apolipoprotein A-II,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37987,0.0768332378651711,0.00525248277603523,0.0665383716241421,0.0871281041062002,4.33399884742211e-48
APOA2,Apolipoprotein A-II,NMR metabolomics,X23564.Triglycerides in Large HDL,37987,0.0169879181138065,0.00445746261166921,0.0082512913949348,0.0257245448326781,0.000138952032697875
APOA2,Apolipoprotein A-II,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37987,0.0897092722843569,0.00469168031798924,0.0805135788610979,0.0989049657076158,1.93734433913958e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23566.Total Lipids in Medium HDL,37987,0.077345779774145,0.00466344162245224,0.0682054341941386,0.0864861253541514,3.55535146936528e-61
APOA2,Apolipoprotein A-II,NMR metabolomics,X23567.Phospholipids in Medium HDL,37987,0.0613806237724288,0.00464799573071814,0.0522705521402213,0.0704906954046364,1.42639154883721e-39
APOA2,Apolipoprotein A-II,NMR metabolomics,X23568.Cholesterol in Medium HDL,37987,0.09942209601199,0.00469900616420877,0.0902120439301408,0.108632148093839,8.83452089057538e-98
APOA2,Apolipoprotein A-II,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37987,0.10157305679004,0.00467136929612654,0.0924171729696319,0.110728940610448,4.55421894906628e-103
APOA2,Apolipoprotein A-II,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37987,0.0869985147685246,0.0047765653714558,0.0776364466404712,0.096360582896578,3.01031617864891e-73
APOA2,Apolipoprotein A-II,NMR metabolomics,X23571.Triglycerides in Medium HDL,37987,-0.0334897119261512,0.00430349100818809,-0.0419245543021998,-0.0250548695501025,7.65519354793722e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23572.Concentration of Small HDL Particles,37987,0.0568412923138007,0.00424019898288008,0.0485305023073558,0.0651520823202457,1.02303914443602e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23573.Total Lipids in Small HDL,37987,0.0390679787711192,0.00429988811053652,0.0306401980744676,0.0474957594677708,1.17027025490951e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23574.Phospholipids in Small HDL,37987,0.0319450916103208,0.00434896180138829,0.0234211264795998,0.0404690567410419,2.16789476651136e-13
APOA2,Apolipoprotein A-II,NMR metabolomics,X23575.Cholesterol in Small HDL,37987,0.0641525181856571,0.00424249675231708,0.0558372245511156,0.0724678118201985,3.06632214097009e-51
APOA2,Apolipoprotein A-II,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37987,0.0622498822944552,0.00419585502398934,0.0540260064474361,0.0704737581414743,2.09294546149166e-49
APOA2,Apolipoprotein A-II,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37987,0.0615437308974328,0.00440431388496384,0.0529112756829037,0.0701761861119619,4.57623155500282e-44
APOA2,Apolipoprotein A-II,NMR metabolomics,X23578.Triglycerides in Small HDL,37987,-0.0461462801221378,0.00443962129858083,-0.0548479378673562,-0.0374446223769193,3.27831823837246e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.0191334168747012,0.00405240709738497,0.0111906989638267,0.0270761347855758,2.36603166059585e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.0502033234357619,0.00420742628751619,0.0419567679122302,0.0584498789592937,1.20007519668014e-32
APOA2,Apolipoprotein A-II,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.0365996887334539,0.00411628595067451,0.0285317682701319,0.0446676091967759,6.8337783546189e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.0604877546384696,0.00428302352910694,0.05209302852142,0.0688824807555193,5.98972553322529e-45
APOA2,Apolipoprotein A-II,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,-0.0427779568711651,0.00408559706958994,-0.0507857271275614,-0.0347701866147688,1.49814926760686e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37782,-0.0423348486609838,0.00396431811763947,-0.0501049121715571,-0.0345647851504104,1.63409580657574e-26
APOA2,Apolipoprotein A-II,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37782,0.0408319749453703,0.0045217798839616,0.0319692863728056,0.0496946635179351,1.94844350943539e-19
APOA2,Apolipoprotein A-II,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37782,0.0472498470378333,0.00452985127636829,0.0383713385361514,0.0561283555395151,2.2466489069595e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37782,0.00820144230105294,0.004284260412341,-0.000195708107135421,0.0165985927092413,0.0556007585449024
APOA2,Apolipoprotein A-II,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37782,-0.0218311780477923,0.00434359324909142,-0.0303446208160114,-0.0133177352795731,5.07141415191834e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37982,-0.0479460704278866,0.00424904632422229,-0.0562742012233623,-0.0396179396324109,2.13095601859518e-29
APOA2,Apolipoprotein A-II,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37982,0.0136198539999151,0.00418628981826987,0.00541472595610618,0.0218249820437241,0.00114295395537577
APOA2,Apolipoprotein A-II,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37982,0.0236310208157633,0.00439313716004506,0.015020471982075,0.0322415696494516,7.61145618640896e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37982,-0.00823814070577485,0.00402608364748684,-0.0161292646548491,-0.000347016756700645,0.040756758320004
APOA2,Apolipoprotein A-II,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37982,0.0104565218025711,0.00395220265955918,0.00271020458983511,0.0182028390153071,0.00816054072948543
APOA2,Apolipoprotein A-II,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37987,0.00271367671856449,0.00443580815494945,-0.00598050726513642,0.0114078607022654,0.540702847323068
APOA2,Apolipoprotein A-II,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37987,0.0283592523667343,0.00464125274749664,0.0192623969816408,0.0374561077518277,1.0219867953171e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37987,0.0318259920181607,0.00467855506588116,0.0226560240890336,0.0409959599472877,1.0711926029317e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37987,0.0176146869260964,0.00453380388999472,0.0087284313017067,0.026500942550486,0.000102737058176734
APOA2,Apolipoprotein A-II,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37987,-0.0228610074349137,0.00460677666336724,-0.0318902896951135,-0.0138317251747139,7.04471237935465e-07
APOA2,Apolipoprotein A-II,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37987,0.0201343910728813,0.00452706023474202,0.0112613530127869,0.0290074291329757,8.75415973525445e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37987,-0.00657334160285344,0.00441526863668759,-0.0152272681307611,0.00208058492505423,0.136569923698781
APOA2,Apolipoprotein A-II,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37987,-0.0251663776149659,0.00428176821217358,-0.0335586433108262,-0.0167741119191057,4.26141177525242e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37987,0.0215854132883762,0.00454155408005252,0.0126839672914733,0.0304868592852792,2.02613151708298e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37987,-0.00151843352409231,0.00445630785225012,-0.0102527969145026,0.00721592986631794,0.733306100578656
APOA2,Apolipoprotein A-II,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37987,-0.0611752490627903,0.00450589861379939,-0.0700068103458371,-0.0523436877797435,1.03223047804747e-41
APOA2,Apolipoprotein A-II,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37987,0.00708311383739729,0.00471760543364983,-0.00216339281255638,0.016329620487351,0.133269924994476
APOA2,Apolipoprotein A-II,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37987,0.00852439511490887,0.00474963519640217,-0.000784889870039393,0.0178336800998571,0.0727162698027538
APOA2,Apolipoprotein A-II,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37987,-0.0072941530961506,0.00458991167680475,-0.0162903799826879,0.00170207379038671,0.112045218713903
APOA2,Apolipoprotein A-II,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37987,0.00927308519461904,0.00470541368983357,5.04743625452317e-05,0.0184956960266928,0.0487754707835629
APOA2,Apolipoprotein A-II,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37987,-0.0185175514294572,0.00424219288535622,-0.0268322494847554,-0.010202853374159,1.28013283898986e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37987,0.0259254754763824,0.00450220156658668,0.0171011604058726,0.0347497905468923,8.67592719730622e-09
APOA2,Apolipoprotein A-II,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37987,0.0103460743904745,0.00449734004226276,0.0015312879076395,0.0191608608733095,0.0214357507257712
APOA2,Apolipoprotein A-II,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37987,0.0424859945813404,0.00457097012112083,0.0335268931439436,0.0514450960187373,1.69810707112104e-20
APOA2,Apolipoprotein A-II,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37987,-0.0265122817987883,0.00464296116924234,-0.0356124856905033,-0.0174120779070733,1.15208021473273e-08
APOA2,Apolipoprotein A-II,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37987,-0.056242868309563,0.00421005106717626,-0.0644945684012285,-0.0479911682178975,1.88821148776598e-40
APOA2,Apolipoprotein A-II,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37987,0.0739707253815009,0.00461578930469662,0.0649237783442956,0.0830176724187063,2.84698862398396e-57
APOA2,Apolipoprotein A-II,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37987,0.0469698626048894,0.00425861885106431,0.0386229696568034,0.0553167555529755,3.63526092424976e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37987,0.0358719070463848,0.00463887195901305,0.0267797180067192,0.0449640960860503,1.12530447369165e-14
APOA2,Apolipoprotein A-II,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37987,-0.0367754256220935,0.00461903396703669,-0.0458287321974854,-0.0277221190467016,1.83126781207479e-15
APOA2,Apolipoprotein A-II,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37987,0.0106971803440696,0.0041834316439665,0.00249765432189525,0.0188967063662439,0.0105676727788023
APOA2,Apolipoprotein A-II,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37987,0.0103040210602469,0.00430090929132636,0.00187423884924727,0.0187338032712466,0.0165986573470995
APOA2,Apolipoprotein A-II,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37987,-0.0480481086375416,0.00434421315428263,-0.0565627664199355,-0.0395334508551476,2.58524473712317e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37987,0.0676838545944854,0.00470390446335151,0.0584642018463164,0.0769035073426543,1.34110231849688e-46
APOA2,Apolipoprotein A-II,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37987,-0.0142748677137806,0.00446593381466872,-0.0230280979905313,-0.0055216374370299,0.00139478356625836
APOA2,Apolipoprotein A-II,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37987,0.00144763446787953,0.00427336050401067,-0.00692815211998139,0.00982342105574046,0.734797402419674
APOA2,Apolipoprotein A-II,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37987,0.0266916432809669,0.00432108223482353,0.0182223221007128,0.035160964461221,6.71705301493532e-10
APOA2,Apolipoprotein A-II,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37987,-0.0182318802032529,0.00431502402383381,-0.0266893272899672,-0.00977443311653866,2.40282113152415e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37987,0.0505842721013938,0.00460765246766565,0.0415532732647691,0.0596152709380185,6.37219874394717e-28
APOA2,Apolipoprotein A-II,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37987,-0.0297643326566726,0.00456327206661946,-0.0387083459072468,-0.0208203194060985,7.15610846394583e-11
APOA2,Apolipoprotein A-II,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37985,0.00905464480813566,0.00491454258658852,-0.000577858661577833,0.0186871482778492,0.0654358007033206
APOA2,Apolipoprotein A-II,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37985,0.0203202962143204,0.004911208594255,0.0106943273695806,0.0299462650590602,3.53180216339712e-05
APOA2,Apolipoprotein A-II,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37985,0.0997410164085406,0.00484827730044599,0.0902383928996664,0.109243639917415,1.25796852412902e-92
APOA2,Apolipoprotein A-II,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37985,-0.102392343066605,0.00515865800138563,-0.112503312749321,-0.0922813733838891,1.91317728074263e-86
APOA2,Apolipoprotein A-II,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37985,-0.0339141178508298,0.00489356004771207,-0.0435054955443454,-0.0243227401573141,4.38781491149719e-12
APOA2,Apolipoprotein A-II,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37987,-0.0958807790784273,0.0050228437650317,-0.105725552857889,-0.0860360052989652,3.51811349863786e-80
APOA2,Apolipoprotein A-II,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37987,0.0922818791983749,0.00501595966258647,0.0824505982597055,0.102113160137044,1.11330461534506e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37987,0.107962473121834,0.00503812663446871,0.0980877449182754,0.117837201325393,3.28212443826571e-100
APOA2,Apolipoprotein A-II,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37987,-0.0227188032212328,0.00492920037501342,-0.0323800359562591,-0.0130575704862065,4.08260714359115e-06
APOA2,Apolipoprotein A-II,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37987,-0.057447147327442,0.00491377804761509,-0.0670781523007676,-0.0478161423541164,2.00562646392667e-31
APOA2,Apolipoprotein A-II,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37987,-0.158864010375594,0.00461249687162047,-0.16790450424397,-0.149823516507218,2.87988396303019e-249
APOA2,Apolipoprotein A-II,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37987,0.115867237608103,0.00459268797556764,0.106865569175991,0.124868906040216,2.8176142346289e-137
APOA2,Apolipoprotein A-II,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37987,0.10785319967936,0.00457170716728063,0.0988926536314903,0.11681374572723,1.26218261632658e-120
APOA2,Apolipoprotein A-II,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37987,0.0913825638171984,0.00499830699493503,0.0815858821071257,0.101179245527271,8.76236693659865e-74
APOA2,Apolipoprotein A-II,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37987,-0.0790645278751258,0.00452288823918443,-0.0879293888239272,-0.0701996669263243,1.10641511409849e-67
APOA2,Apolipoprotein A-II,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37987,-0.0458226710897181,0.00441865979204248,-0.0544832442821214,-0.0371620978973148,4.20402592861269e-25
APOA2,Apolipoprotein A-II,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37987,0.0790013960936496,0.00440880375915038,0.0703601407257149,0.0876426514615844,5.52770245753031e-71
APOA2,Apolipoprotein A-II,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37987,0.0612549733606516,0.00444429248419709,0.0525441600916253,0.0699657866296779,6.30119413595597e-43
APOA2,Apolipoprotein A-II,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37987,0.0572922896320618,0.00454714096301918,0.0483798933445442,0.0662046859195794,3.38641595775372e-36
APOA2,Apolipoprotein A-II,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37987,-0.0748073481709811,0.00452746413971518,-0.0836811778848229,-0.0659335184571394,9.84502770160061e-61
APOA2,Apolipoprotein A-II,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48311,-0.0035803859249472,0.00366859584605317,-0.0107708337832114,0.00361006193331702,0.329096461610438
APOA2,Apolipoprotein A-II,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48311,-0.001366725542875,0.00359514138073373,-0.00841320264911311,0.0056797515633631,0.703830736421194
APOA2,Apolipoprotein A-II,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46603,-0.00204223904094487,0.00343697647061934,-0.00877871292335877,0.00469423484146904,0.552386829530408
APOA2,Apolipoprotein A-II,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46603,-0.00286256570683243,0.00375928578672228,-0.0102307658488081,0.00450563443514323,0.446387299398317
APOA2,Apolipoprotein A-II,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46603,-0.00262180365931443,0.00367772207189493,-0.0098301389202285,0.00458653160159964,0.4759226207421
APOA2,Apolipoprotein A-II,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46603,-0.00592393210693016,0.00337579171524125,-0.012540483868803,0.000692619654942694,0.0793026436653912
APOA2,Apolipoprotein A-II,Working and living environment,X24009.Traffic intensity on the nearest road,48311,-0.0126919703003453,0.0544770516210625,-0.119466991477628,0.0940830508769371,0.815780263056043
APOA2,Apolipoprotein A-II,Working and living environment,X24010.Inverse distance to the nearest road,48311,0.00227198212120409,0.00321647630951071,-0.00403231144543691,0.00857627568784508,0.47997274957727
APOA2,Apolipoprotein A-II,Working and living environment,X24011.Traffic intensity on the nearest major road,48311,-0.00610702161434595,0.00321834417660604,-0.0124149762004938,0.000200932971801879,0.0577652910702964
APOA2,Apolipoprotein A-II,Working and living environment,X24012.Inverse distance to the nearest major road,48311,-0.0021295090697358,0.00328258365481396,-0.00856337303317116,0.00430435489369957,0.516519434266293
APOA2,Apolipoprotein A-II,Working and living environment,X24013.Total traffic load on major roads,48311,-0.00282369730531172,0.0380045044812667,-0.0773125260885945,0.0716651314779711,0.940773082495063
APOA2,Apolipoprotein A-II,Working and living environment,X24015.Sum of road length of major roads within 100m,48311,-0.010471460518811,0.036832638871252,-0.082663432706465,0.061720511668843,0.776184174922855
APOA2,Apolipoprotein A-II,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48311,0.000337101777950608,0.00365644666299148,-0.00682953368151269,0.00750373723741391,0.926544823727177
APOA2,Apolipoprotein A-II,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48311,-0.000481770402046336,0.0036496574881327,-0.00763509907878642,0.00667155827469375,0.89498202102048
APOA2,Apolipoprotein A-II,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48311,0.000437076135665566,0.00361553291497215,-0.00664936837767985,0.00752352064901099,0.903780416140612
APOA2,Apolipoprotein A-II,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48253,0.00125270332314028,0.00355439803867173,-0.00571391683265631,0.00821932347893686,0.724513268793414
APOA2,Apolipoprotein A-II,Working and living environment,X24020.Average daytime sound level of noise pollution,48311,-0.00238370334569494,0.00324326002048705,-0.00874049298584957,0.00397308629445968,0.46236413839322
APOA2,Apolipoprotein A-II,Working and living environment,X24021.Average evening sound level of noise pollution,48311,-0.00233368460576694,0.00324335672356984,-0.00869066378396383,0.00402329457242995,0.471822964455013
APOA2,Apolipoprotein A-II,Working and living environment,X24022.Average night-time sound level of noise pollution,48311,-0.00238356516929202,0.00324319686225831,-0.0087402310193183,0.00397310068073426,0.462381369083453
APOA2,Apolipoprotein A-II,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48311,-0.0023515263453059,0.00324326575181183,-0.00870832721885708,0.00400527452824529,0.46842912722477
APOA2,Apolipoprotein A-II,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48311,-0.00234175315358931,0.00324335709012909,-0.00869873305024233,0.00401522674306371,0.47029220164181
APOA2,Apolipoprotein A-II,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45602,0.000356684667104426,0.00376319066945468,-0.00701916904502674,0.0077325383792356,0.924488475142979
APOA2,Apolipoprotein A-II,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45602,0.0016355092837556,0.00343464351429246,-0.00509639200425761,0.00836741057176882,0.633950913023556
APOA2,Apolipoprotein A-II,Working and living environment,"X24502.Water percentage, buffer 1000m",45602,-0.000875984835182145,0.00335966860373407,-0.00746093529850093,0.00570896562813664,0.794299034841243
APOA2,Apolipoprotein A-II,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45602,-0.0007609542508197,0.0035449582581876,-0.00770907243686739,0.00618716393522799,0.83003590768256
APOA2,Apolipoprotein A-II,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45602,0.000587130331954965,0.00346440569976938,-0.00620310483959301,0.00737736550350294,0.865424615885032
APOA2,Apolipoprotein A-II,Working and living environment,"X24505.Water percentage, buffer 300m",45602,0.00213594252971829,0.0033882697336552,-0.00450506614824591,0.00877695120768249,0.528444105934319
APOA2,Apolipoprotein A-II,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48462,0.00166430327878646,0.00357894256428947,-0.0053504241472209,0.00867903070479381,0.641916667799081
APOA2,Apolipoprotein A-II,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48462,-0.00274184125739269,0.0033785543237477,-0.0093638077319382,0.00388012521715281,0.417062099720966
APOA2,Apolipoprotein A-II,Working and living environment,X24508.Distance (Euclidean) to coast,48462,0.000677084727298024,0.00321726438704958,-0.00562875347131915,0.0069829229259152,0.833315483528583
APOA2,Apolipoprotein A-II,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34278,0.0130391350285293,0.0401053046959463,-0.0655672621755255,0.0916455322325841,0.745095319164789
APOA2,Apolipoprotein A-II,Health and medical history,X2704.Years since last cervical smear test,42831,0.0514507756683691,0.0293347036502979,-0.00604524348621478,0.108946794822953,0.0794605777934947
APOA2,Apolipoprotein A-II,Health and medical history,X2714.Age when periods started (menarche),47873,0.00363825812549004,0.0248124379513305,-0.0449941202591177,0.0522706365100978,0.88342500589091
APOA2,Apolipoprotein A-II,Health and medical history,X2734.Number of live births,48606,-0.0754352929652966,0.0239331976816881,-0.122344360421405,-0.0285262255091879,0.00162404369255793
APOA2,Apolipoprotein A-II,Health and medical history,X2744.Birth weight of first child,43637,-0.00968512657245705,0.0266967548240948,-0.0620107660276828,0.0426405128827687,0.716771052884037
APOA2,Apolipoprotein A-II,Health and medical history,X2754.Age at first live birth,40771,-0.00236713975318775,0.00408420650447929,-0.0103721845019671,0.00563790499559165,0.56220334958636
APOA2,Apolipoprotein A-II,Health and medical history,X2764.Age at last live birth,40722,-0.00774672753496954,0.00392268580355559,-0.0154351917099385,-5.82633600005903e-05,0.0483017201673811
APOA2,Apolipoprotein A-II,Health and medical history,X2794.Age started oral contraceptive pill,42958,0.0036565631273054,0.00441548604888358,-0.00499778952850642,0.0123109157831172,0.407611835624837
APOA2,Apolipoprotein A-II,Health and medical history,X2804.Age when last used oral contraceptive pill,41234,-0.00975209473827962,0.00383321504961734,-0.0172651962355296,-0.00223899324102964,0.0109647548986001
APOA2,Apolipoprotein A-II,Lifestyle factors,X2867.Age started smoking in former smokers,29381,0.014005446040195,0.00760527724350714,-0.000900897357079038,0.028911789437469,0.0656020549192045
APOA2,Apolipoprotein A-II,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33926,0.0705636790645853,0.0449609004435132,-0.0175596858047005,0.158687043933871,0.116577591576987
APOA2,Apolipoprotein A-II,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33919,0.00892299177794196,0.0485149565224808,-0.0861663230061204,0.104012306562004,0.854078198472812
APOA2,Apolipoprotein A-II,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33948,-0.0439472167195953,0.0533667796181355,-0.148546104771141,0.0606516713319503,0.410247877625021
APOA2,Apolipoprotein A-II,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33906,-0.0416223990825974,0.0511250660744605,-0.14182752858854,0.0585827304233452,0.415591561737058
APOA2,Apolipoprotein A-II,Mental health,X28739.Difficulty with standing for long periods,33965,0.0852350085731576,0.0451682374482541,-0.00329473682542041,0.173764753971736,0.0591831786097045
APOA2,Apolipoprotein A-II,Mental health,X28740.Difficulty with taking care of household responsibilities,33989,-0.026579504915157,0.0485219874355573,-0.121682600288849,0.0685235904585352,0.583853947798594
APOA2,Apolipoprotein A-II,Mental health,X28741.Difficulty learning a new task,33891,0.0270618955442066,0.054547492362678,-0.0798511894866422,0.133974980575055,0.619823973775522
APOA2,Apolipoprotein A-II,Mental health,X28742.Difficulty with joining in community activities,33649,0.111458089397386,0.0574559022176919,-0.00115547894928984,0.224071657744063,0.0524236882322967
APOA2,Apolipoprotein A-II,Mental health,X28743.Difficulty with being emotionally affected by health problems,33921,0.0650545503417437,0.0478943878599906,-0.0288184498638378,0.158927550547325,0.174403507439002
APOA2,Apolipoprotein A-II,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33979,-0.0141287163604442,0.0700246091024522,-0.151376950201251,0.123119517480362,0.840102508648347
APOA2,Apolipoprotein A-II,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29361,0.0323142762092448,0.0534081472299079,-0.0723656923613746,0.136994244779864,0.545177769065704
APOA2,Apolipoprotein A-II,Lifestyle factors,X2897.Age stopped smoking,29390,-0.00813656577835301,0.0077939779126299,-0.0234127624871076,0.0071396309304016,0.296557090729987
APOA2,Apolipoprotein A-II,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33011,0.0251326819943622,0.0107462380535397,0.00407005540942434,0.0461953085793,0.0193716635984194
APOA2,Apolipoprotein A-II,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33011,-0.0314183892832523,0.0114496316357125,-0.0538596672892487,-0.00897711127725581,0.00608122980981169
APOA2,Apolipoprotein A-II,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33011,0.000774931333356652,0.0385910992417242,-0.0748636231804229,0.0764134858471362,0.983979566672722
APOA2,Apolipoprotein A-II,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33011,0.0556234624993409,0.0414825714922421,-0.0256823776254535,0.136929302624135,0.179992558054867
APOA2,Apolipoprotein A-II,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33011,0.0313227602871561,0.0423018610671744,-0.0515888874045057,0.114234407978818,0.459042321394539
APOA2,Apolipoprotein A-II,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33011,0.0213194345608467,0.0344875611739971,-0.0462761853401877,0.088915054461881,0.53647478464977
APOA2,Apolipoprotein A-II,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33011,-0.0225181329958974,0.016258878315223,-0.0543855344937345,0.00934926850193972,0.16609634064806
APOA2,Apolipoprotein A-II,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33011,-0.0344073032576761,0.0281568989550109,-0.0895948252094974,0.0207802186941452,0.221747018145609
APOA2,Apolipoprotein A-II,Mental health,X29002.Recent lack of interest or pleasure in doing things,32951,-0.0379528825630055,0.0536679491988997,-0.143142062992849,0.0672362978668378,0.479474224872246
APOA2,Apolipoprotein A-II,Mental health,X29003.Recent feelings of depression,32938,-0.0471159176478911,0.0513684583924117,-0.147798096097018,0.0535662608012359,0.359056089994541
APOA2,Apolipoprotein A-II,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32956,0.0102121226946235,0.0420294913678108,-0.0721656803862856,0.0925899257755327,0.808030496195172
APOA2,Apolipoprotein A-II,Mental health,X29005.Recent feelings of tiredness or low energy,32964,-0.0103437966038359,0.0429390027483091,-0.0945042419905218,0.07381664878285,0.809642200745211
APOA2,Apolipoprotein A-II,Mental health,X29006.Recent poor appetite or overeating,32969,0.0231916369164625,0.0546564264661364,-0.0839349589571649,0.13031823279009,0.67134554919003
APOA2,Apolipoprotein A-II,Mental health,X29007.Recent feelings of inadequacy,32925,0.0536162045790056,0.0553579970842002,-0.0548854697060268,0.162117878864038,0.332804476826664
APOA2,Apolipoprotein A-II,Mental health,X29008.Recent trouble concentrating on things,32967,-0.0889340277967321,0.0562906046991553,-0.199263613007076,0.0213955574136123,0.114164881039846
APOA2,Apolipoprotein A-II,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32956,-0.0212845024367395,0.0999223365852387,-0.217132282143807,0.174563277270328,0.831323914544884
APOA2,Apolipoprotein A-II,Mental health,X29010.Recent thoughts of suicide or self-harm,32898,0.0863533860238284,0.109948994302516,-0.129146642809104,0.301853414856761,0.43224407057213
APOA2,Apolipoprotein A-II,Mental health,X29038#0.Substances taken for depression_None of options listed,32048,0.000118205325008154,0.0208720744722086,-0.0407910606405208,0.0410274712905371,0.995481493910776
APOA2,Apolipoprotein A-II,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32048,0.0074331191093479,0.0411770709544885,-0.0732739399614496,0.0881401781801454,0.856752329830337
APOA2,Apolipoprotein A-II,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32048,-0.0197031775623338,0.0195323200531743,-0.0579865248665554,0.0185801697418878,0.313127912342076
APOA2,Apolipoprotein A-II,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32048,0.0774609501650736,0.0580503837830764,-0.0363178020497562,0.191239702379903,0.182121161042605
APOA2,Apolipoprotein A-II,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32048,-0.0243316716193031,0.0361373463615042,-0.0951608704878514,0.0464975272492451,0.500769961732189
APOA2,Apolipoprotein A-II,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32048,0.00717354863335404,0.037663872827784,-0.0666476421091027,0.0809947393758108,0.848951955999114
APOA2,Apolipoprotein A-II,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32048,-0.0408863883165245,0.0450338119831685,-0.129152659803535,0.0473798831704859,0.363957625510417
APOA2,Apolipoprotein A-II,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32048,0.0303828451831471,0.0488260666104633,-0.0653162453733609,0.126081935739655,0.533785058973236
APOA2,Apolipoprotein A-II,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32048,0.0308115530055593,0.0371687703906025,-0.0420392369600217,0.10366234297114,0.407151123562723
APOA2,Apolipoprotein A-II,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32048,0.00334871457932025,0.0209171904085328,-0.0376489786214041,0.0443464077800446,0.872811363524887
APOA2,Apolipoprotein A-II,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32048,-0.00297550972021156,0.0316393129905482,-0.0649885631816861,0.0590375437412629,0.925076128470802
APOA2,Apolipoprotein A-II,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32048,-0.0539815115204256,0.0493488779363691,-0.150705312275709,0.0427422892348579,0.274044423059344
APOA2,Apolipoprotein A-II,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32048,-0.170751940990516,0.0651323902204941,-0.298411425822685,-0.0430924561583478,0.00876891503986709
APOA2,Apolipoprotein A-II,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32048,-0.0256495343968843,0.0431957441343103,-0.110313192900132,0.0590141241063639,0.552665095760876
APOA2,Apolipoprotein A-II,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32048,-0.0257769537534022,0.0724708646600637,-0.167819848487127,0.116265940980323,0.722084762309375
APOA2,Apolipoprotein A-II,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32048,-0.0976178536011844,0.0668968158943087,-0.228735612754029,0.0334999055516606,0.1445431113655
APOA2,Apolipoprotein A-II,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32048,-0.0716660020453769,0.036250094750929,-0.142716187757198,-0.000615816333555966,0.0480790914191851
APOA2,Apolipoprotein A-II,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32048,-0.0442250204215592,0.0352471000234767,-0.113309336467573,0.0248592956244551,0.209621302530286
APOA2,Apolipoprotein A-II,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32048,-0.135828727686765,0.0493546171089583,-0.232563777220323,-0.0390936781532066,0.0059355362062712
APOA2,Apolipoprotein A-II,Mental health,X29058.Recent feelings or nervousness or anxiety,32827,0.0469672846986311,0.0476937263481713,-0.0465124189437845,0.140446988341047,0.324766196322873
APOA2,Apolipoprotein A-II,Mental health,X29059.Recent inability to stop or control worrying,32839,0.026419989692686,0.0486809046490139,-0.0689945834193812,0.121834562804753,0.587338594649778
APOA2,Apolipoprotein A-II,Mental health,X29060.Recent worrying too much about different things,32830,0.0503417135430515,0.0458200620090389,-0.0394656079946647,0.140149035080768,0.271938031582188
APOA2,Apolipoprotein A-II,Mental health,X29061.Recent trouble relaxing,32838,0.0449036049756354,0.0483621844232175,-0.0498862764938709,0.139693486445142,0.35318232255217
APOA2,Apolipoprotein A-II,Mental health,X29062.Recent restlessness,32846,0.0255919996962557,0.0696002191833403,-0.110824429903091,0.162008429295603,0.713106223068348
APOA2,Apolipoprotein A-II,Mental health,X29063.Recent easy annoyance or irritability,32813,0.0502701117745028,0.0507260775686274,-0.0491530002600069,0.149693223809012,0.321708789063139
APOA2,Apolipoprotein A-II,Mental health,X29064.Recent feelings of foreboding,32805,0.0679851407962089,0.0548291167413512,-0.0394799280168395,0.175450209609257,0.215030229247895
APOA2,Apolipoprotein A-II,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32048,-0.0297508994692098,0.0208095300279209,-0.0705375783239348,0.0110357793855152,0.152850966987619
APOA2,Apolipoprotein A-II,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32048,-0.0264643580404515,0.0358420588741436,-0.0967147934337729,0.0437860773528699,0.460318264065703
APOA2,Apolipoprotein A-II,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32048,0.0135122887362878,0.0453330049077111,-0.075340400882826,0.102364978355402,0.76565991106506
APOA2,Apolipoprotein A-II,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32048,-0.00551690074109717,0.0501019361296632,-0.103716695555237,0.0926828940730427,0.91232225177138
APOA2,Apolipoprotein A-II,Mental health,X29065#2.Symptoms of panic attack_Sweating,32048,0.00629996980440946,0.0338160793616295,-0.0599795457443844,0.0725794853532033,0.852213688851762
APOA2,Apolipoprotein A-II,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32048,-0.000938938250981799,0.0338439474659152,-0.0672730752841756,0.065395198782212,0.977867724294604
APOA2,Apolipoprotein A-II,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32048,0.0245937222315328,0.0349737088127564,-0.0439547470414698,0.0931421915045353,0.48194892612221
APOA2,Apolipoprotein A-II,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32048,-0.0252152515686903,0.0311042908383111,-0.08617966161178,0.0357491584743994,0.417581783234784
APOA2,Apolipoprotein A-II,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32048,-0.00418308441019259,0.0420573753785167,-0.0866155401520853,0.0782493713317002,0.920774578217766
APOA2,Apolipoprotein A-II,Mental health,X29076.Felt loved as a child,32808,-0.00683994187138854,0.0448892844312009,-0.0948229393565422,0.0811430556137651,0.878895958213943
APOA2,Apolipoprotein A-II,Mental health,X29077.Physically abused by family as a child,32824,0.0893793909167955,0.0624794784448756,-0.0330803868351606,0.211839168668752,0.152599438288524
APOA2,Apolipoprotein A-II,Mental health,X29078.Felt hated by family member as a child,32804,0.0329812651966944,0.0579744795475434,-0.0806487147164906,0.146611245109879,0.569444180211253
APOA2,Apolipoprotein A-II,Mental health,X29079.Sexually molested as a child,32715,0.042271937492567,0.0739186293144918,-0.102608575963837,0.187152450948971,0.567424777726633
APOA2,Apolipoprotein A-II,Mental health,X29080.Someone to take to doctor when needed as a child,32787,-0.0689817346962728,0.0631552385398325,-0.192766002234344,0.0548025328417989,0.274751851797986
APOA2,Apolipoprotein A-II,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32801,0.134409291743173,0.0779208110468912,-0.0183154979087334,0.28713408139508,0.0845739849088454
APOA2,Apolipoprotein A-II,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32735,-0.00947103818466047,0.0587879371834324,-0.124695395064188,0.105753318694867,0.87201453043415
APOA2,Apolipoprotein A-II,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32802,0.0184940696258951,0.0653798081640949,-0.109650354375731,0.146638493627521,0.777282528334414
APOA2,Apolipoprotein A-II,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32764,-0.0184999784752253,0.0813422935594707,-0.177930873851788,0.140930916901337,0.820092115294511
APOA2,Apolipoprotein A-II,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32772,0.0955233839774821,0.0808527414627179,-0.062947989289445,0.253994757244409,0.237458207148519
APOA2,Apolipoprotein A-II,Mental health,X29086.Experienced a violent or sexual assault,32803,0.139141017571716,0.0750729893714817,-0.00800204159638859,0.28628407673982,0.063858886752135
APOA2,Apolipoprotein A-II,Mental health,X29087.Experienced a life-threatening injury or illness,32815,0.0545857770370509,0.0536379253208079,-0.0505445565917327,0.159716110665834,0.308863634928803
APOA2,Apolipoprotein A-II,Mental health,X29088.Experienced a marital separation or divorce,32818,-0.0358080092907999,0.0481086991919842,-0.130101059707089,0.0584850411254892,0.456707052211208
APOA2,Apolipoprotein A-II,Mental health,X29089.Experienced the death of a spouse or partner,32824,0.0104094812357709,0.060505062702575,-0.108180441661276,0.128999404132818,0.863407769236757
APOA2,Apolipoprotein A-II,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32810,0.036706773678677,0.0610317925274904,-0.0829155396752042,0.156329087032558,0.547565324129883
APOA2,Apolipoprotein A-II,Lifestyle factors,X29091.Frequency of drinking alcohol,32820,0.0932986723358179,0.040812289317593,0.0133065852733357,0.1732907593983,0.0222765954515748
APOA2,Apolipoprotein A-II,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31724,0.0819285625916017,0.0497848348785538,-0.0156497137703639,0.179506838953567,0.0998784558598075
APOA2,Apolipoprotein A-II,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31739,0.145265931540646,0.0511859120368476,0.0449415439484253,0.245590319132868,0.00455218305379656
APOA2,Apolipoprotein A-II,Mental health,X29104.Ever used cannabis,32815,0.185139629766472,0.0616095058117191,0.064384998375503,0.305894261157442,0.00266324958305333
APOA2,Apolipoprotein A-II,Mental health,X29108.Ever thought that life not worth living,32770,0.031918175576131,0.048473694813414,-0.0630902662581605,0.126926617410422,0.510258347135037
APOA2,Apolipoprotein A-II,Mental health,X29109.Ever contemplated self-harm,32798,0.00888396099376398,0.0642143424722313,-0.116976150251809,0.134744072239337,0.889968297312855
APOA2,Apolipoprotein A-II,Mental health,X29111.Ever self-harmed,32812,0.054267033775729,0.0997803690226608,-0.141302489508686,0.249836557060144,0.586548994981161
APOA2,Apolipoprotein A-II,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32804,-0.0079889809836034,0.0668910928319077,-0.139095522934142,0.123117560966936,0.904935462308369
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32666,-0.0352065675103227,0.043868689227645,-0.121189198396507,0.0507760633758615,0.422261379201342
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32666,-0.0793870563514283,0.0344474593395483,-0.146904076656943,-0.0118700360459135,0.0212147151701335
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32666,-0.0745725518585753,0.0349840212401966,-0.143141233489361,-0.00600387022778988,0.0330678986907099
APOA2,Apolipoprotein A-II,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32666,-0.0693253779277663,0.0451829950254287,-0.157884048177607,0.0192332923220739,0.124988346150363
APOA2,Apolipoprotein A-II,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32799,0.0356640867036577,0.0448830918210482,-0.0523067732655967,0.123634946672912,0.42686904640692
APOA2,Apolipoprotein A-II,Health and medical history,X29153.Pain or discomfort today,32810,0.0300599719104594,0.0430999835914066,-0.0544159959286976,0.114535939749616,0.485542247284084
APOA2,Apolipoprotein A-II,Mental health,X29154.Anxiety or depression today,32810,-0.0236711267035717,0.051470525297748,-0.124553356287158,0.0772111028800142,0.645602308451644
APOA2,Apolipoprotein A-II,Mental health,X29166.Frequency of confiding in someone close,32598,-0.0878894106241992,0.0416440082092136,-0.169511666714258,-0.00626715453414069,0.0348462815303635
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32781,0.013787193847944,0.0114958009530202,-0.00874457601997566,0.0363189637158636,0.23043597279185
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32781,0.00690196790910044,0.0112761909430936,-0.015199366339363,0.0290033021575639,0.540499369007567
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32781,-0.0225467410683215,0.0165640249044992,-0.0550122298811399,0.009918747744497,0.173491316619395
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32781,-0.0287879224130712,0.0143198254286454,-0.0568547802532161,-0.000721064572926196,0.0444258819421002
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32781,-0.00851444076651516,0.0211400124453039,-0.0499488651593109,0.0329199836262805,0.687132017134386
APOA2,Apolipoprotein A-II,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32781,-0.0127367817069438,0.0112222552561705,-0.034732402009038,0.00925883859515043,0.256425825915293
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32781,-0.00515853775864085,0.0124362213506584,-0.0295335316059313,0.0192164560886496,0.678299406577249
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32781,-0.00871611497524288,0.0174054200074236,-0.042830738189793,0.0253985082393073,0.616546120581166
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32781,-0.0311976773161306,0.0368665609567767,-0.103456136791413,0.0410607821591517,0.397447437745529
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32781,0.0153614986065793,0.0240068466073714,-0.0316919207438685,0.0624149179570272,0.522268282424943
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32781,-0.019403025168307,0.0334334505210918,-0.084932588189647,0.046126537853033,0.561695885513515
APOA2,Apolipoprotein A-II,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32781,0.010832361634001,0.0176109889662797,-0.0236851767399071,0.0453499000079091,0.538511398837955
APOA2,Apolipoprotein A-II,Mental health,X29171.Frequency of feeling 'in tune' with people,32686,-0.0111818740835328,0.0521395048928178,-0.113375303673456,0.0910115555063901,0.830193131638292
APOA2,Apolipoprotein A-II,Mental health,X29172.Freuency of feeling that lacks companionship,32759,0.0183066667793582,0.0464508185317351,-0.0727369375428425,0.109350271101559,0.693510983852006
APOA2,Apolipoprotein A-II,Mental health,X29173.Frequency of feeling left out,32705,-0.0318340452650893,0.0485438511449568,-0.126979993509205,0.0633119029790259,0.511984518410508
APOA2,Apolipoprotein A-II,Mental health,X29174.Frequency of feeling isolated from others,32732,-0.0134599869188711,0.0503636541450501,-0.112172749043169,0.0852527752054272,0.789278746809584
APOA2,Apolipoprotein A-II,Mental health,X29175.Tendency to bounce back quickly after hard times,32798,0.0726427686284338,0.0425479535731974,-0.010751220375033,0.156036757631901,0.0878006861413449
APOA2,Apolipoprotein A-II,Mental health,X29176.Ability to make it through stressful events,32798,-0.0640741843203553,0.0412448456349024,-0.144914081764764,0.0167657131240534,0.120339827130332
APOA2,Apolipoprotein A-II,Mental health,X29177.Quick recovery from stressful events,32798,0.0491913190700674,0.0420111650448407,-0.0331505644178203,0.131533202557955,0.241668149945244
APOA2,Apolipoprotein A-II,Mental health,X29178.Hard to snap back when something bad happens,32798,-0.0613271861837243,0.0415773480203759,-0.142818788303661,0.0201644159362125,0.140246412033628
APOA2,Apolipoprotein A-II,Mental health,X29179.Comes through difficult times with little trouble,32798,0.0831707657996889,0.0418738929781762,0.00109793556246354,0.165243596036914,0.0470415632894672
APOA2,Apolipoprotein A-II,Mental health,X29180.Tendency to take a long time to get over setbacks,32798,-0.0672973112667178,0.0418654621650606,-0.149353617110237,0.014758994576801,0.107990000292689
APOA2,Apolipoprotein A-II,Mental health,X29181.General happiness,32750,-0.0431812702959316,0.0437373264124882,-0.128906430064408,0.0425438894725453,0.3235310251181
APOA2,Apolipoprotein A-II,Mental health,X29182.Belief that own life is meaningful,32658,0.0311135681728651,0.0432160792600768,-0.0535899471768855,0.115817083522616,0.471574129181075
APOA2,Apolipoprotein A-II,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28986,0.0556482857620997,0.054147883141803,-0.0504815651958343,0.161778136720034,0.304141403143947
APOA2,Apolipoprotein A-II,Health and medical history,X2946.Father's age,29842,0.0118386532759386,0.00996104623277107,-0.00768499734029271,0.0313623038921699,0.234690824643451
APOA2,Apolipoprotein A-II,Health and medical history,X2966.Age high blood pressure diagnosed,29589,-0.0180865800876731,0.00859226214051095,-0.0349274138830745,-0.00124574629227159,0.035341080819869
APOA2,Apolipoprotein A-II,Blood and urine assays,X30000.White blood cell (leukocyte) count,47826,-0.0375964827666342,0.0033950790968389,-0.0442508377964385,-0.03094212773683,1.97821397790141e-28
APOA2,Apolipoprotein A-II,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47826,-0.0324012979346127,0.00400318989046395,-0.040247550119922,-0.0245550457493033,6.05923251926486e-16
APOA2,Apolipoprotein A-II,Blood and urine assays,X30020.Haemoglobin concentration,47826,-0.0552566289140299,0.00433849903646483,-0.063760087025501,-0.0467531708025588,4.93153838164193e-37
APOA2,Apolipoprotein A-II,Blood and urine assays,X30030.Haematocrit percentage,47826,-0.040269324589166,0.00421846862571407,-0.0485375230955655,-0.0320011260827664,1.47631982847545e-21
APOA2,Apolipoprotein A-II,Blood and urine assays,X30040.Mean corpuscular volume,47826,-0.00100035108870284,0.00334818651577423,-0.00756279665962034,0.00556209448221466,0.765115143941338
APOA2,Apolipoprotein A-II,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47825,-0.0135841963621105,0.00335593763413067,-0.0201618341250066,-0.00700655859921438,5.18655860287071e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47825,-0.029582600567563,0.00328450565682532,-0.0360202316549406,-0.0231449694801854,2.28163395547821e-19
APOA2,Apolipoprotein A-II,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47826,0.0387266678668908,0.00316345535704107,0.0325262953670903,0.0449270403666913,2.36584373381268e-34
APOA2,Apolipoprotein A-II,Blood and urine assays,X30080.Platelet count,47826,0.0114744469644923,0.0033582636063656,0.00489225029601577,0.0180566436329689,0.000634743906694186
APOA2,Apolipoprotein A-II,Blood and urine assays,X30090.Platelet crit,47826,0.0137085935690498,0.00344536744547521,0.0069556733759184,0.0204615137621812,6.94587986151317e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47826,0.000326171420179228,0.00324668387765665,-0.00603732898002781,0.00668967182038627,0.919977662094548
APOA2,Apolipoprotein A-II,Blood and urine assays,X30110.Platelet distribution width,47826,-0.00336270271721658,0.00325476442335433,-0.00974204098699106,0.00301663555255791,0.301538236374306
APOA2,Apolipoprotein A-II,Blood and urine assays,X30120.Lymphocyte count,47793,-0.0521665741042218,0.00335822511046691,-0.058748695320737,-0.0455844528877067,3.81546808402514e-54
APOA2,Apolipoprotein A-II,Blood and urine assays,X30130.Monocyte count,47793,-0.0289566487455126,0.0034310297226159,-0.0356814670018398,-0.0222318304891855,3.36570168485688e-17
APOA2,Apolipoprotein A-II,Blood and urine assays,X30140.Neutrophill count,47793,-0.0213792948296339,0.0033824295928083,-0.0280088568315381,-0.0147497328277296,2.65103878127428e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30150.Eosinophill count,47793,-0.00602911027755469,0.00333424505012593,-0.0125642305758015,0.000506010020692138,0.0705822534049509
APOA2,Apolipoprotein A-II,Blood and urine assays,X30160.Basophill count,47793,-0.0995906299017705,0.0270020734600293,-0.152514693883428,-0.0466665659201131,0.000226306333625429
APOA2,Apolipoprotein A-II,Blood and urine assays,X30170.Nucleated red blood cell count,47793,0.193852772291547,0.11870919636394,-0.038817252581776,0.426522797164869,0.102481325655654
APOA2,Apolipoprotein A-II,Blood and urine assays,X30180.Lymphocyte percentage,47793,-0.0236135658159944,0.0033356821058369,-0.0301515027434347,-0.0170756288885541,1.49222044649403e-12
APOA2,Apolipoprotein A-II,Blood and urine assays,X30190.Monocyte percentage,47793,-0.00198985171159192,0.0033919228609058,-0.00863802051896729,0.00465831709578345,0.557448396366031
APOA2,Apolipoprotein A-II,Blood and urine assays,X30200.Neutrophill percentage,47793,0.0177502242147336,0.00331145731341612,0.011259767880438,0.0242406805490292,8.3897329752226e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30210.Eosinophill percentage,47793,0.00670092082179401,0.00329181031509766,0.000248972604202602,0.0131528690393854,0.0417983968249822
APOA2,Apolipoprotein A-II,Blood and urine assays,X30220.Basophill percentage,47793,-0.000373573817255362,0.00315753918370144,-0.00656235061731019,0.00581520298279947,0.905821708192271
APOA2,Apolipoprotein A-II,Blood and urine assays,X30230.Nucleated red blood cell percentage,47793,0.196344057993255,0.119037496834695,-0.0369694358027474,0.429657551789257,0.0990729619348807
APOA2,Apolipoprotein A-II,Blood and urine assays,X30240.Reticulocyte percentage,47388,-0.0141096998033126,0.00346872177078562,-0.0209083944740524,-0.00731100513257278,4.7639271446344e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30250.Reticulocyte count,47388,-0.0203534981592635,0.00358348646005148,-0.0273771316209644,-0.0133298646975626,1.36481393357173e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30260.Mean reticulocyte volume,47388,0.0287225424504938,0.00330991998449998,0.0222350992808738,0.0352099856201137,4.30186888281439e-18
APOA2,Apolipoprotein A-II,Blood and urine assays,X30270.Mean sphered cell volume,47388,0.00858800329769072,0.00335225517378561,0.00201758315707092,0.0151584234383105,0.0104177052591029
APOA2,Apolipoprotein A-II,Blood and urine assays,X30280.Immature reticulocyte fraction,47388,0.00660715244702564,0.00351056220209757,-0.000273549469085601,0.0134878543631369,0.0598380542926768
APOA2,Apolipoprotein A-II,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47388,-0.00861959861149503,0.00356625528199259,-0.0156094589642005,-0.00162973825878956,0.015657254357994
APOA2,Apolipoprotein A-II,Blood and urine assays,X30300.High light scatter reticulocyte count,47388,-0.0138526001120457,0.00365600098393537,-0.021018362040559,-0.00668683818353235,0.000151639284995613
APOA2,Apolipoprotein A-II,Blood and urine assays,X30500.Microalbumin in urine,31171,0.0338705110788839,0.00664806850247106,0.0208402968140406,0.0469007253437271,3.58649123951419e-07
APOA2,Apolipoprotein A-II,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47871,-0.013594702600797,0.00347114876973264,-0.0203981541894729,-0.00679125101212098,9.01040726001582e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30520.Potassium in urine,47826,-0.00698969120786796,0.00322547370850337,-0.0133116196765346,-0.000667762739201359,0.0302428005187531
APOA2,Apolipoprotein A-II,Blood and urine assays,X30530.Sodium in urine,47801,-0.0144102231199341,0.00339919382050121,-0.0210726430081165,-0.00774780323175175,2.25072985290034e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30600.Albumin,45383,0.0218767347603171,0.00356093617647209,0.0148972998544318,0.0288561696662024,8.21614706763367e-10
APOA2,Apolipoprotein A-II,Blood and urine assays,X30610.Alkaline phosphatase,47448,-0.0253897846943462,0.00339216091837668,-0.0320384200943645,-0.0187411492943279,7.420567181472e-14
APOA2,Apolipoprotein A-II,Blood and urine assays,X30620.Alanine aminotransferase,47456,-0.0148090876280478,0.00353665484548,-0.0217409311251886,-0.00787724413090698,2.83324026662081e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30630.Apolipoprotein A,45181,0.152294221833932,0.00375916111471082,0.144926266049099,0.159662177618765,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30640.Apolipoprotein B,47353,-0.024599118943282,0.00337035253739149,-0.0312050099165693,-0.0179932279699947,3.00082942736536e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30650.Aspartate aminotransferase,47388,0.0246661370633838,0.00340826934003276,0.0179859291569196,0.031346344969848,4.72651964611673e-13
APOA2,Apolipoprotein A-II,Blood and urine assays,X30660.Direct bilirubin,42316,0.0319388290181598,0.00381062427799246,0.0244700054332946,0.039407652603025,5.6083013137567e-17
APOA2,Apolipoprotein A-II,Blood and urine assays,X30670.Urea,47445,0.0117487060457767,0.00354804072555978,0.00479454622367953,0.0187028658678739,0.000929992477537915
APOA2,Apolipoprotein A-II,Blood and urine assays,X30680.Calcium,45386,0.0354618458826777,0.00341861088719265,0.0287613685437801,0.0421623232215753,3.7791841367662e-25
APOA2,Apolipoprotein A-II,Blood and urine assays,X30690.Cholesterol,47456,0.0156738551166778,0.00347541375960408,0.00886204414785377,0.0224856660855017,6.51709050090145e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30700.Creatinine,47451,0.0841169101860126,0.00389532427265602,0.0764820746116068,0.0917517457604184,2.11290257273325e-102
APOA2,Apolipoprotein A-II,Blood and urine assays,X30710.C-reactive protein,47395,-0.0587712641379211,0.00367794636262355,-0.0659800390086632,-0.0515624892671789,3.62188066815942e-57
APOA2,Apolipoprotein A-II,Blood and urine assays,X30720.Cystatin C,47454,0.118900568271009,0.00374814330751979,0.11155420738827,0.126246929153748,3.42894098012799e-216
APOA2,Apolipoprotein A-II,Blood and urine assays,X30730.Gamma glutamyltransferase,47452,0.00976377768774145,0.00348322470411152,0.00293665726768286,0.0165908981078,0.00506585656645384
APOA2,Apolipoprotein A-II,Blood and urine assays,X30740.Glucose,45362,-0.0220631914075215,0.00370066215886779,-0.0293164892389024,-0.0148098935761407,2.53235216752191e-09
APOA2,Apolipoprotein A-II,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47378,-0.00821285564429615,0.00376337738113251,-0.0155890753113159,-0.000836635977276439,0.0290967846070774
APOA2,Apolipoprotein A-II,Blood and urine assays,X30760.HDL cholesterol,45373,0.162393667127293,0.00397156732333334,0.154609395173559,0.170177939081026,0
APOA2,Apolipoprotein A-II,Blood and urine assays,X30770.IGF-1,47327,-0.0294415686833559,0.00339621738055592,-0.0360981547492455,-0.0227849826174662,4.64668160997901e-18
APOA2,Apolipoprotein A-II,Blood and urine assays,X30780.LDL direct,47405,-0.0185768423422883,0.00338219245652936,-0.0252059395570859,-0.0119477451274908,4.00386595977385e-08
APOA2,Apolipoprotein A-II,Blood and urine assays,X30790.Lipoprotein A,42866,-0.00210052398211924,0.00369643196588769,-0.00934553063525911,0.00514448267102064,0.569867283526895
APOA2,Apolipoprotein A-II,Blood and urine assays,X30810.Phosphate,45344,0.0285352185229239,0.00369125597828271,0.0213003568054898,0.035770080240358,1.11960291074384e-14
APOA2,Apolipoprotein A-II,Blood and urine assays,X30830.SHBG,45147,0.115536808943974,0.00380069606260726,0.108087444661264,0.122986173226684,1.30455741298987e-198
APOA2,Apolipoprotein A-II,Blood and urine assays,X30840.Total bilirubin,47372,0.040472707703337,0.0034040160617852,0.033800836222238,0.047144579184436,1.66870582017129e-32
APOA2,Apolipoprotein A-II,Blood and urine assays,X30850.Testosterone,43496,-0.0181071035446571,0.00599964840945859,-0.029866414427196,-0.00634779266211831,0.00254762221975367
APOA2,Apolipoprotein A-II,Blood and urine assays,X30860.Total protein,45381,0.0143906382909875,0.00348529483439012,0.00755946041558284,0.0212218161663921,3.65822535938311e-05
APOA2,Apolipoprotein A-II,Blood and urine assays,X30870.Triglycerides,47449,-0.0669093426721683,0.00374025602002214,-0.0742402444714117,-0.0595784408729249,4.36118196251291e-71
APOA2,Apolipoprotein A-II,Blood and urine assays,X30880.Urate,47423,0.0187216111744567,0.00416659530022526,0.0105550843860152,0.0268881379628982,7.04819294624721e-06
APOA2,Apolipoprotein A-II,Blood and urine assays,X30890.Vitamin D,46119,0.0163892947276092,0.00370303792950052,0.00913134038578818,0.0236472490694302,9.65074081521057e-06
APOA2,Apolipoprotein A-II,Physical measures,X3137.Number of measurements made,46482,0.0400161250358332,0.0302510625491938,-0.0192759575605867,0.0993082076322531,0.185915414157712
APOA2,Apolipoprotein A-II,Physical measures,X3143.Ankle spacing width,38097,0.00158951827382569,0.00580259773802369,-0.00978357329270073,0.0129626098403521,0.784140884070775
APOA2,Apolipoprotein A-II,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",38096,-0.0238680714176578,0.00470739164681359,-0.0330945590454125,-0.0146415837899032,4.02312765187543e-07
APOA2,Apolipoprotein A-II,Physical measures,X3146.Speed of sound through heel,38097,-0.0153709683076285,0.00454212659065953,-0.0242735364253212,-0.00646840018993579,0.000716154030364451
APOA2,Apolipoprotein A-II,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",38097,-0.0190027709576743,0.0045987918290762,-0.0280164029426636,-0.00998913897268489,3.615737947943e-05
APOA2,Apolipoprotein A-II,Physical measures,X3148.Heel bone mineral density (BMD),38095,-0.0188076050471638,0.00458741455523546,-0.0277989375754253,-0.00981627251890227,4.1585464976394e-05
APOA2,Apolipoprotein A-II,Health and medical history,X3526.Mother's age at death,38839,-0.00611944201885154,0.00435495990404067,-0.0146551634307713,0.00241627939306818,0.159993484239672
APOA2,Apolipoprotein A-II,Health and medical history,X3581.Age at menopause (last menstrual period),38289,-0.00966629621481346,0.00429656105268569,-0.0180875558780774,-0.00124503655154951,0.0244788730576238
APOA2,Apolipoprotein A-II,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29437,0.00305654107449216,0.00720752705945894,-0.0110702119620474,0.0171832941110317,0.671528501402634
APOA2,Apolipoprotein A-II,Physical measures,X4100.Ankle spacing width (left),32316,0.00273885945419105,0.00763079882780095,-0.0122175062482988,0.0176952251566809,0.719663284878149
APOA2,Apolipoprotein A-II,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32315,-0.0200815491971241,0.00618446881578583,-0.0322031080760644,-0.00795999031818391,0.00117078850473543
APOA2,Apolipoprotein A-II,Physical measures,X4103.Speed of sound through heel (left),32316,-0.0131510635103431,0.0060292957855843,-0.0249684832500883,-0.00133364377059784,0.0291985945837749
APOA2,Apolipoprotein A-II,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32316,-0.0160169848183693,0.00608024464144861,-0.0279342643156086,-0.00409970532113006,0.00844844719556998
APOA2,Apolipoprotein A-II,Physical measures,X4105.Heel bone mineral density (BMD) (left),32314,-0.0156948730288695,0.00606406980357421,-0.027580449843875,-0.00380929621386409,0.00966635393133125
APOA2,Apolipoprotein A-II,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32316,-0.0160083304673249,0.00607985996997716,-0.0279248560084802,-0.00409180492616971,0.00847974491685364
APOA2,Apolipoprotein A-II,Physical measures,X4119.Ankle spacing width (right),32317,0.00305231022117555,0.00753095971446262,-0.0117083708191712,0.0178129912615223,0.685266834974419
APOA2,Apolipoprotein A-II,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32317,-0.0253214689955112,0.00618852759024252,-0.0374509830723865,-0.0131919549186358,4.32538574172141e-05
APOA2,Apolipoprotein A-II,Physical measures,X4122.Speed of sound through heel (right),32317,-0.0180638284889271,0.00605228335338246,-0.0299263038615567,-0.00620135311629747,0.00284794306966108
APOA2,Apolipoprotein A-II,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32317,-0.0213491343409697,0.00609400034751563,-0.0332933750221003,-0.00940489365983909,0.000462079701330089
APOA2,Apolipoprotein A-II,Physical measures,X4124.Heel bone mineral density (BMD) (right),32314,-0.021692336559849,0.00608429993921906,-0.0336175644407184,-0.00976710867897965,0.000365602680704006
APOA2,Apolipoprotein A-II,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32317,-0.0213490322871794,0.00609399789121672,-0.0332932681539642,-0.00940479642039461,0.000462106263851319
APOA2,Apolipoprotein A-II,Physical measures,X4194.Pulse rate,32557,-0.0342380439130697,0.00595446396755526,-0.045908793289478,-0.0225672945366613,9.24925043765305e-09
APOA2,Apolipoprotein A-II,Physical measures,X4195.Pulse wave reflection index,32557,-0.000688234790986579,0.00591969691247116,-0.01229084073943,0.0109143711574569,0.907447916750934
APOA2,Apolipoprotein A-II,Physical measures,X4196.Pulse wave peak to peak time,32555,0.0145786333769948,0.00539137420228578,0.00401153994051468,0.0251457268134749,0.00686396334407245
APOA2,Apolipoprotein A-II,Physical measures,X4198.Position of the pulse wave peak,32557,-0.0107580283379439,0.0052298375265334,-0.0210085098899493,-0.000507546785938392,0.0397135096407054
APOA2,Apolipoprotein A-II,Physical measures,X4199.Position of pulse wave notch,32557,-0.0220674727302878,0.00583987582151909,-0.0335136293404652,-0.0106213161201104,0.000158742761369387
APOA2,Apolipoprotein A-II,Physical measures,X4200.Position of the shoulder on the pulse waveform,32557,-0.0154586954680249,0.0052153776032637,-0.0256808355704217,-0.00523655536562801,0.00304491844740696
APOA2,Apolipoprotein A-II,Physical measures,X4269.Number of triplets attempted (left),32465,-0.133482098652972,0.129965361675698,-0.388214207537341,0.121250010231397,0.304423723894054
APOA2,Apolipoprotein A-II,Physical measures,X4270.Volume level set by participant (left),32381,-0.00192854956712251,0.0419070448470165,-0.0840663574672749,0.0802092583330299,0.963295708811912
APOA2,Apolipoprotein A-II,Physical measures,X4276.Number of triplets attempted (right),32467,-0.0443138061913208,0.127095488683507,-0.293420964010995,0.204793351628353,0.727349655706205
APOA2,Apolipoprotein A-II,Physical measures,X4277.Volume level set by participant (right),32369,-0.0457617040779548,0.041665259004307,-0.127425611726397,0.035902203570487,0.272099066351206
APOA2,Apolipoprotein A-II,Cognitive function,X4288.Time to answer,32616,-0.00993832374258955,0.00670040723270043,-0.0230711219186824,0.0031944744335033,0.138048794136627
APOA2,Apolipoprotein A-II,Cognitive function,X4290.Duration screen displayed,32616,0.00335545776913697,0.00588708010695224,-0.00818321924048942,0.0148941347787634,0.568713876819993
APOA2,Apolipoprotein A-II,Physical measures,X46.Hand grip strength (left),48535,-0.022087612119431,0.0048896374831916,-0.0316713015864865,-0.0125039226523754,6.2951573935819e-06
APOA2,Apolipoprotein A-II,Physical measures,X47.Hand grip strength (right),48538,-0.018384148479957,0.00488813587386427,-0.0279648947927309,-0.00880340216718299,0.000169653907150281
APOA2,Apolipoprotein A-II,Physical measures,X48.Waist circumference,48613,-0.0649112392516678,0.0065195884328595,-0.0776896325800724,-0.0521328459232632,2.62398800044848e-23
APOA2,Apolipoprotein A-II,Health and medical history,X4803.Tinnitus,32462,0.024617318577325,0.0506539643506675,-0.0746644515499834,0.123899088704633,0.626987577046816
APOA2,Apolipoprotein A-II,Working and living environment,X4825.Noisy workplace,32595,0.136417702196793,0.072070597083289,-0.00484066808645345,0.277676072480039,0.0584153385396725
APOA2,Apolipoprotein A-II,Working and living environment,X4836.Loud music exposure frequency,32541,-0.0691100844781568,0.0838206724677284,-0.233398602514904,0.095178433558591,0.409680239279611
APOA2,Apolipoprotein A-II,Physical measures,X49.Hip circumference,48611,-0.00191351301768637,0.00553953675650418,-0.0127710050604346,0.00894397902506182,0.72977537780079
APOA2,Apolipoprotein A-II,Physical measures,X50.Standing height,48608,-0.00130443573475136,0.00453537368080259,-0.0101937681491244,0.00758489667962171,0.773644902136015
APOA2,Apolipoprotein A-II,Health and medical history,X5057.Number of older siblings,31654,0.0162771801816627,0.0449391116265681,-0.0718034786064109,0.104357838969736,0.717209318281846
APOA2,Apolipoprotein A-II,Physical measures,X51.Seated height,48499,-0.0142915216195582,0.00454825878981015,-0.0232061088475861,-0.00537693439153029,0.00167889122376831
APOA2,Apolipoprotein A-II,Eye measures,X5181.Ever had eye surgery,29957,-0.12941641547348,0.102261663267626,-0.329849275478026,0.071016444531066,0.205730731747994
APOA2,Apolipoprotein A-II,Eye measures,X5186.Duration visual-acuity screen displayed (right),29944,0.0079270468198692,0.00679483179108771,-0.00539082349066271,0.0212449171304011,0.243410940638739
APOA2,Apolipoprotein A-II,Eye measures,X5188.Duration visual-acuity screen displayed (left),29944,0.0112064316205346,0.00678043280707323,-0.00208321668132888,0.0244960799223982,0.0984367721507301
APOA2,Apolipoprotein A-II,Eye measures,X5190.Duration at which refractometer first shown (right),29876,0.0122060150541176,0.00682347841356856,-0.00116800263647676,0.025580032744712,0.0736986409744216
APOA2,Apolipoprotein A-II,Eye measures,X5193.Duration at which refractometer first shown (left),29875,0.0156810492530036,0.0068613421396704,0.00223281865924965,0.0291292798467576,0.0223266245265112
APOA2,Apolipoprotein A-II,Eye measures,"X5199.logMAR, initial (right)",29926,0.0315190008267874,0.0530668628746713,-0.0724920504075684,0.135530052061143,0.552570889469697
APOA2,Apolipoprotein A-II,Eye measures,X5200.Final number of letters displayed (right),29926,-0.0349048286790782,0.393841031098338,-0.806833249631821,0.737023592273665,0.92938183580268
APOA2,Apolipoprotein A-II,Eye measures,"X5201.logMAR, final (right)",29882,-0.0018999557460593,0.00708402314985526,-0.0157846411197756,0.011984729627657,0.78855330964319
APOA2,Apolipoprotein A-II,Eye measures,X5202.Number of rounds to result (right),29926,0.0933126417719492,0.0497583654568068,-0.00421375452339215,0.190839038067291,0.0608026082251083
APOA2,Apolipoprotein A-II,Eye measures,"X5206.logMAR, initial (left)",29924,-0.0249353648809212,0.0531699960932909,-0.129148557223771,0.0792778274619289,0.639106649908097
APOA2,Apolipoprotein A-II,Eye measures,X5207.Final number of letters displayed (left),29924,-0.0608216705085458,0.321172580259239,-0.690319927816655,0.568676586799563,0.849806887223082
APOA2,Apolipoprotein A-II,Eye measures,"X5208.logMAR, final (left)",29869,-0.00150591004881135,0.00699488844662707,-0.0152158914042004,0.0122040713065777,0.829551502118384
APOA2,Apolipoprotein A-II,Eye measures,X5209.Number of rounds to result (left),29922,-0.00966325651802738,0.0500109253803763,-0.107684670263565,0.0883581572275101,0.846791585793537
APOA2,Apolipoprotein A-II,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29668,-0.00439237626016,0.00694419011246508,-0.0180029888805916,0.00921823636027155,0.527071376832325
APOA2,Apolipoprotein A-II,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29668,-0.00284585268898792,0.00698563419701009,-0.0165376957151277,0.0108459903371519,0.683740898217008
APOA2,Apolipoprotein A-II,Eye measures,X5256.Corneal hysteresis (right),29668,0.00139729869027795,0.00690339015387047,-0.0121333460113082,0.0149279433918641,0.839605974983325
APOA2,Apolipoprotein A-II,Eye measures,X5257.Corneal resistance factor (right),29668,-0.00108445934502275,0.00690144749532014,-0.0146112964358502,0.0124423777458047,0.875144491192849
APOA2,Apolipoprotein A-II,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29662,-0.00857266372298297,0.00696057830824244,-0.0222153972071382,0.00507006976117222,0.218153296220212
APOA2,Apolipoprotein A-II,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29662,-0.00904553479481802,0.0068913265592855,-0.0225525348510176,0.00446146526138157,0.189376587542414
APOA2,Apolipoprotein A-II,Eye measures,X5264.Corneal hysteresis (left),29662,0.00151926127933269,0.00703890938836521,-0.0122770011218631,0.0153155236805285,0.829122790986231
APOA2,Apolipoprotein A-II,Eye measures,X5265.Corneal resistance factor (left),29662,-0.00303084984183799,0.00694845626918671,-0.0166498241294439,0.010588124445768,0.662716673783444
APOA2,Apolipoprotein A-II,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29271,0.299359670156184,0.230770972314229,-0.152951435579706,0.751670775892073,0.194619179141986
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48534,0.0308352736019745,0.0188428855264941,-0.00609678202995389,0.0677673292339029,0.101760356315314
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48534,0.0866304952201683,0.0196505533512868,0.0481154106516462,0.12514557978869,1.04513851159014e-05
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48534,0.106388044863295,0.0516748048758431,0.00510542730664292,0.207670662419948,0.0395242127100784
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48534,0.0123902859458936,0.00827317544214822,-0.00382513792071687,0.0286057098125042,0.134238422972313
APOA2,Apolipoprotein A-II,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48534,-0.0244201165968649,0.00756705165922494,-0.0392515378489458,-0.00958869534478405,0.00125190948522341
APOA2,Apolipoprotein A-II,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35581,-0.0267699607234039,0.00956778583756997,-0.045522820965041,-0.00801710048176674,0.00515202191425106
APOA2,Apolipoprotein A-II,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35581,0.0157227045585564,0.0236425733623335,-0.0306167392316172,0.0620621483487299,0.506053634105588
APOA2,Apolipoprotein A-II,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35581,-0.00786164100993363,0.0187660285191272,-0.0446430569074229,0.0289197748875556,0.675275816965698
APOA2,Apolipoprotein A-II,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35581,0.0262688707393964,0.0115090597358616,0.00371111365710763,0.0488266278216852,0.0224814773234847
APOA2,Apolipoprotein A-II,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48605,0.0256674294468031,0.0153916515268679,-0.00450020754585797,0.0558350664394641,0.0954041036202245
APOA2,Apolipoprotein A-II,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48605,0.0256674294468031,0.0153916515268679,-0.00450020754585797,0.0558350664394641,0.0954041036202245
APOA2,Apolipoprotein A-II,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48605,-0.00428629684400071,0.0124808688365661,-0.0287487997636702,0.0201762060756688,0.731278461388487
APOA2,Apolipoprotein A-II,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48605,-0.000296480007357126,0.0192536218821416,-0.0380335788963547,0.0374406188816405,0.987714258399884
APOA2,Apolipoprotein A-II,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48605,0.00582081353499791,0.0491589336280459,-0.090530696375972,0.102172323445968,0.905745331311577
APOA2,Apolipoprotein A-II,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48605,0.0784183822331618,0.0338483035320763,0.0120757073102923,0.144761057156031,0.0205251535330415
APOA2,Apolipoprotein A-II,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48605,0.0183034580993528,0.052905597595234,-0.0853915131873059,0.121998429386012,0.729372414785923
APOA2,Apolipoprotein A-II,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48534,0.0118895912766356,0.0100445834506717,-0.00779779228668095,0.0315769748399523,0.236550703932814
APOA2,Apolipoprotein A-II,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48534,0.0107271850761379,0.0167944660032816,-0.0221899682902941,0.0436443384425698,0.523002505393487
APOA2,Apolipoprotein A-II,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48534,-0.017283138374849,0.00893494159652769,-0.0347956239040433,0.000229347154345218,0.0530840904621613
APOA2,Apolipoprotein A-II,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48534,-0.00595392349509071,0.0164321689914894,-0.03816097471841,0.0262531277282286,0.717106088825081
APOA2,Apolipoprotein A-II,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48534,0.0202594447238999,0.0161475196588252,-0.0113896938073976,0.0519085832551973,0.209618938379018
APOA2,Apolipoprotein A-II,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48534,0.0301584862928881,0.00898080724325918,0.0125561040961001,0.0477608684896761,0.000786006027410299
APOA2,Apolipoprotein A-II,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30883,0.0618481360248777,0.0370584506060252,-0.0107864271629317,0.134482699212687,0.0951789873715795
APOA2,Apolipoprotein A-II,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30883,0.07038112128817,0.0241684852021659,0.023010890291925,0.117751352284415,0.0036023869713086
APOA2,Apolipoprotein A-II,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30883,0.0951460984244103,0.0305012061616021,0.0353637343476702,0.15492846250115,0.00182008304213697
APOA2,Apolipoprotein A-II,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30883,-0.00473200034969424,0.0271799028434878,-0.0580046099229304,0.0485406092235419,0.861792952688552
APOA2,Apolipoprotein A-II,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48522,0.0135919059819416,0.0244159959744242,-0.0342634461279297,0.061447258091813,0.57775099798093
APOA2,Apolipoprotein A-II,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48522,0.0676510925800326,0.04275011917941,-0.0161391410116109,0.151441326171676,0.113553792043045
APOA2,Apolipoprotein A-II,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48522,0.0842848454779001,0.0684953364504247,-0.0499660139649323,0.218535704920733,0.218514663569946
APOA2,Apolipoprotein A-II,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48522,0.100889937740601,0.0648316281596738,-0.0261800534523597,0.227959928933562,0.119677509469821
APOA2,Apolipoprotein A-II,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48522,0.0421582104779839,0.020516417836612,0.00194603151822442,0.0823703894377434,0.039904032133377
APOA2,Apolipoprotein A-II,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48522,0.0191428654739314,0.0294130138469534,-0.0385066416660972,0.07679237261396,0.515162583611801
APOA2,Apolipoprotein A-II,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48522,0.00810128097757869,0.0144892537069193,-0.0202976562879832,0.0365002182431406,0.576082699244568
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32728,0.0362151040011443,0.0221185138003889,-0.00713718304761792,0.0795673910499066,0.101601463804985
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32728,0.0139873941366963,0.025478845433885,-0.0359511429137184,0.0639259311871109,0.583033512392955
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32728,0.0878159404304378,0.0331325732005249,0.022876096957409,0.152755783903467,0.00805396512156903
APOA2,Apolipoprotein A-II,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32728,0.00660720704352659,0.0115117713674579,-0.0159558648366908,0.029170278923744,0.566015713638018
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35794,0.0349463004759685,0.0119157145440985,0.0115914999695354,0.0583011009824015,0.00336601803186315
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35794,-0.0323887789932531,0.010377676048041,-0.0527290240474135,-0.0120485339390928,0.00180687509475987
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35794,0.00687515395283542,0.00975301034968193,-0.0122407463325412,0.025991054238212,0.480870548355759
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35794,3.30827723707732e-05,0.0232563096612027,-0.0455492841635864,0.045615449708328,0.998865011561761
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35794,0.0369508597778878,0.0139540100694794,0.00960100004170806,0.0643007195140675,0.00810705495387746
APOA2,Apolipoprotein A-II,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35794,0.0576758397510971,0.0162938994082032,0.0257397969110188,0.0896118825911755,0.000402156033564182
APOA2,Apolipoprotein A-II,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48534,0.011699298123264,0.0221079851518844,-0.0316323527744295,0.0550309490209574,0.596679363297276
APOA2,Apolipoprotein A-II,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48534,0.010057895416663,0.0140294065299826,-0.0174397413821029,0.0375555322154289,0.473433347683155
APOA2,Apolipoprotein A-II,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48534,0.0786825385974813,0.057207715695856,-0.0334445841663965,0.190809661361359,0.169025427213266
APOA2,Apolipoprotein A-II,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48534,0.0240975475430233,0.0138781058328469,-0.00310353988935652,0.0512986349754032,0.0825109553650026
APOA2,Apolipoprotein A-II,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48534,0.0118725444499978,0.0165844627723177,-0.0206330025837449,0.0443780914837405,0.474070184244187
APOA2,Apolipoprotein A-II,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48534,0.0144437975777021,0.0186150112703742,-0.0220416245122313,0.0509292196676354,0.437802636300174
APOA2,Apolipoprotein A-II,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48534,-0.00144542596475184,0.00663474677281047,-0.0144495296394604,0.0115586777099567,0.827542384635293
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28262,0.0581255593862002,0.0233134039960092,0.0124312875540221,0.103819831218378,0.0127009710099219
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28262,-0.041979856026344,0.0312136009120441,-0.10315851381395,0.0191988017612623,0.178730481153344
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28262,-0.0825028126751619,0.020546175280652,-0.12277331622524,-0.042232309125084,6.04666899595058e-05
APOA2,Apolipoprotein A-II,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28262,0.0144481768951074,0.0184474509806859,-0.0217088270270369,0.0506051808172517,0.433554100183621
APOA2,Apolipoprotein A-II,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48641,0.00334178038474652,0.00756127830435484,-0.011478325091789,0.018161885861282,0.658522310621882
APOA2,Apolipoprotein A-II,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48641,0.0432172104921525,0.0203960848207021,0.00324088424357633,0.0831935367407286,0.0341093038562233
APOA2,Apolipoprotein A-II,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48641,0.00944156917418229,0.00739853876411703,-0.00505956680348708,0.0239427051518517,0.201918386320351
APOA2,Apolipoprotein A-II,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48641,0.0170341914634299,0.0073704055827795,0.00258819652118212,0.0314801864056778,0.0208323463889869
APOA2,Apolipoprotein A-II,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48641,0.0268797422447542,0.0106199127816247,0.0060647131927697,0.0476947712967386,0.0113777984660728
APOA2,Apolipoprotein A-II,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48641,0.00799833663088606,0.00939528189926825,-0.0104164158916797,0.0264130891534518,0.39460328192037
APOA2,Apolipoprotein A-II,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48641,0.0188829862921072,0.00788910020503335,0.00342034989024178,0.0343456226939725,0.0166936034885842
APOA2,Apolipoprotein A-II,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48641,0.0725376151257937,0.0213907351199427,0.0306117742907059,0.114463455960881,0.000697300510003959
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,41130,0.022401531521635,0.00786967515047294,0.00697696822670803,0.0378260948165619,0.00442478192784976
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,41130,0.00836849942702411,0.00870556985735557,-0.0086944174933928,0.025431416347441,0.336424804137023
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,41130,-0.00249820401432848,0.00875094699672174,-0.0196500601279031,0.0146536520992461,0.775281399842567
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,41130,-0.00889599729544071,0.0111479398104884,-0.0307459593239981,0.0129539647331166,0.424884906166492
APOA2,Apolipoprotein A-II,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,41130,-0.00192796426117525,0.00792919802263131,-0.0174691923855326,0.0136132638631821,0.807894166225984
APOA2,Apolipoprotein A-II,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48430,-0.0204789314640677,0.00795280344500971,-0.0360664262162868,-0.0048914367118487,0.0100282604315508
APOA2,Apolipoprotein A-II,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48430,0.00645790761227753,0.00642697153043896,-0.00613895658738284,0.0190547718119379,0.314996812712545
APOA2,Apolipoprotein A-II,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48430,0.00710506390897093,0.00702121756154826,-0.00665652251166365,0.0208666503296055,0.311576067399853
APOA2,Apolipoprotein A-II,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48430,0.0148277098712824,0.0154963514612056,-0.0155451389926806,0.0452005587352454,0.338651771942711
APOA2,Apolipoprotein A-II,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48441,-0.0252864364061508,0.00725602152192039,-0.0395082385891148,-0.0110646342231869,0.000493218346402168
APOA2,Apolipoprotein A-II,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48441,0.0192167387539744,0.0131264907532226,-0.00651118312234186,0.0449446606302907,0.143216287661141
APOA2,Apolipoprotein A-II,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48534,0.00813762454635235,0.00693157480160917,-0.00544826206480162,0.0217235111575063,0.240409193580924
APOA2,Apolipoprotein A-II,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48534,-0.0017800900284803,0.00786567757488732,-0.0171968180752594,0.0136366380182988,0.820961397935218
APOA2,Apolipoprotein A-II,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48534,0.0242299483658883,0.0102783007953445,0.00408447880701308,0.0443754179247635,0.0184119347036422
APOA2,Apolipoprotein A-II,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48534,0.00562876366962093,0.0149949438772488,-0.0237613263297867,0.0350188536690286,0.707383085384941
APOA2,Apolipoprotein A-II,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48534,0.0384254922073396,0.0152890983861366,0.00845885937051191,0.0683921250441674,0.0119685593926139
APOA2,Apolipoprotein A-II,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48534,-0.0236783690267735,0.0200063585184246,-0.0628908317228856,0.0155340936693387,0.236606025728384
APOA2,Apolipoprotein A-II,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",38097,-0.0190047943861241,0.00459878187390994,-0.0280184068589876,-0.0099911819132606,3.60868947476285e-05
APOA2,Apolipoprotein A-II,Physical activities,X864.Number of days or week walked 10+ minutes,48091,0.0239742304919962,0.0244700382901561,-0.0239870445567097,0.0719355055407021,0.327225409423074
APOA2,Apolipoprotein A-II,Physical activities,X874.Duration of walks,44521,0.00642604811379322,0.00354061845590886,-0.000513564059788141,0.0133656602873746,0.0695463996723993
APOA2,Apolipoprotein A-II,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47145,0.0833810576621048,0.023739153869177,0.036852316078518,0.129909799245692,0.000444966676524777
APOA2,Apolipoprotein A-II,Physical activities,X894.Duration of moderate activity,41767,0.00353300849298174,0.029165315669637,-0.0536310102195068,0.0606970272054703,0.903583666876431
APOA2,Apolipoprotein A-II,Physical activities,X90087.No-wear time bias adjusted average acceleration,29569,-0.00204406930791624,0.00722458952969386,-0.0162042647861162,0.0121161261702837,0.777240223474552
APOA2,Apolipoprotein A-II,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47170,0.0587529545432684,0.0245410337126906,0.0106525284663948,0.106853380620142,0.0166706244747891
APOA2,Apolipoprotein A-II,Physical activities,X914.Duration of vigorous activity,36383,0.00245657713932626,0.00470499070198903,-0.00676520463657224,0.0116783589152248,0.601595381205146
